<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
	<head>
		<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
		<meta http-equiv="Content-Style-Type" content="text/css" />
		<meta name="generator" content="MediaWiki 1.15alpha" />
		<meta name="keywords" content="Multiple myeloma,Articles with unsourced statements since February 2007,Lymphoid malignancy,Chromosomal abnormalities,Lymphatic disease,Myeloid malignancy,22q11.2 deletion syndrome,48, XXXX,49, XXXXX,49 XXXXY syndrome,AIDS-related lymphoma" />
		<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Multiple_myeloma&amp;action=edit" />
		<link rel="edit" title="Edit this page" href="/w/index.php?title=Multiple_myeloma&amp;action=edit" />
		<link rel="apple-touch-icon" href="http://en.wikipedia.org/apple-touch-icon.png" />
		<link rel="shortcut icon" href="/favicon.ico" />
		<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)" />
		<link rel="copyright" href="http://www.gnu.org/copyleft/fdl.html" />
		<link rel="alternate" type="application/rss+xml" title="Wikipedia RSS Feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=rss" />
		<link rel="alternate" type="application/atom+xml" title="Wikipedia Atom Feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=atom" />
		<title>Multiple myeloma - Wikipedia, the free encyclopedia</title>
		<link rel="stylesheet" href="/skins-1.5/common/shared.css?207xx" type="text/css" media="screen" />
		<link rel="stylesheet" href="/skins-1.5/common/commonPrint.css?207xx" type="text/css" media="print" />
		<link rel="stylesheet" href="/skins-1.5/monobook/main.css?207xx" type="text/css" media="screen" />
		<link rel="stylesheet" href="/skins-1.5/chick/main.css?207xx" type="text/css" media="handheld" />
		<!--[if lt IE 5.5000]><link rel="stylesheet" href="/skins-1.5/monobook/IE50Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<!--[if IE 5.5000]><link rel="stylesheet" href="/skins-1.5/monobook/IE55Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<!--[if IE 6]><link rel="stylesheet" href="/skins-1.5/monobook/IE60Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<!--[if IE 7]><link rel="stylesheet" href="/skins-1.5/monobook/IE70Fixes.css?207xx" type="text/css" media="screen" /><![endif]-->
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Common.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" />
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Print.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" media="print" />
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Handheld.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" media="handheld" />
		<link rel="stylesheet" href="/w/index.php?title=MediaWiki:Monobook.css&amp;usemsgcache=yes&amp;ctype=text%2Fcss&amp;smaxage=2678400&amp;action=raw&amp;maxage=2678400" type="text/css" />
		<link rel="stylesheet" href="/w/index.php?title=-&amp;action=raw&amp;maxage=2678400&amp;gen=css" type="text/css" />
		<!--[if lt IE 7]><script type="text/javascript" src="/skins-1.5/common/IEFixes.js?207xx"></script>
		<meta http-equiv="imagetoolbar" content="no" /><![endif]-->

		<script type= "text/javascript">/*<![CDATA[*/
		var skin = "monobook";
		var stylepath = "/skins-1.5";
		var wgArticlePath = "/wiki/$1";
		var wgScriptPath = "/w";
		var wgScript = "/w/index.php";
		var wgVariantArticlePath = false;
		var wgActionPaths = {};
		var wgServer = "http://en.wikipedia.org";
		var wgCanonicalNamespace = "";
		var wgCanonicalSpecialPageName = false;
		var wgNamespaceNumber = 0;
		var wgPageName = "Multiple_myeloma";
		var wgTitle = "Multiple myeloma";
		var wgAction = "view";
		var wgArticleId = "292137";
		var wgIsArticle = true;
		var wgUserName = null;
		var wgUserGroups = null;
		var wgUserLanguage = "en";
		var wgContentLanguage = "en";
		var wgBreakFrames = false;
		var wgCurRevisionId = 281211687;
		var wgVersion = "1.15alpha";
		var wgEnableAPI = true;
		var wgEnableWriteAPI = true;
		var wgSeparatorTransformTable = ["", ""];
		var wgDigitTransformTable = ["", ""];
		var wgMWSuggestTemplate = "http://en.wikipedia.org/w/api.php?action=opensearch\x26search={searchTerms}\x26namespace={namespaces}\x26suggest";
		var wgDBname = "enwiki";
		var wgSearchNamespaces = [0];
		var wgMWSuggestMessages = ["with suggestions", "no suggestions"];
		var wgRestrictionEdit = [];
		var wgRestrictionMove = [];
		/*]]>*/</script>

		<script type="text/javascript" src="/skins-1.5/common/wikibits.js?207xx"><!-- wikibits js --></script>
		<!-- Head Scripts -->
		<script type="text/javascript" src="/skins-1.5/common/ajax.js?207xx"></script>
		<script type="text/javascript" src="/skins-1.5/common/mwsuggest.js?207xx"></script>
<script type="text/javascript">/*<![CDATA[*/
var wgNotice='';var wgNoticeLocal='';
/*]]>*/</script>		<script type="text/javascript" src="http://upload.wikimedia.org/centralnotice/wikipedia/en/centralnotice.js?207xx"></script>
		<script type="text/javascript" src="/w/index.php?title=-&amp;action=raw&amp;gen=js&amp;useskin=monobook"><!-- site js --></script>
	</head>
<body class="mediawiki ltr ns-0 ns-subject page-Multiple_myeloma skin-monobook">
	<div id="globalWrapper">
		<div id="column-content">
	<div id="content">
		<a name="top" id="top"></a>
		<div id="siteNotice"><script type='text/javascript'>if (wgNotice != '') document.writeln(wgNotice);</script></div>		<h1 id="firstHeading" class="firstHeading">Multiple myeloma</h1>
		<div id="bodyContent">
			<h3 id="siteSub">From Wikipedia, the free encyclopedia</h3>
			<div id="contentSub"></div>
									<div id="jump-to-nav">Jump to: <a href="#column-one">navigation</a>, <a href="#searchInput">search</a></div>			<!-- start content -->
			<table class="infobox" width="200" cellspacing="0" style="font-size: 95%; text-align:left">
<tr>
<td style="text-align: center; background: lightgrey; font-size: 95%;" colspan="2"><b>Multiple myeloma</b><br />
<i>Classification and external resources</i></td>
</tr>
<tr>
<th colspan="2" style="text-align: center; font-size: smaller;">
<div class="center">
<div class="floatnone"><a href="/wiki/File:Multiple_myeloma_(2)_HE_stain.jpg" class="image" title="Multiple myeloma (2) HE stain.jpg"><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/thumb/2/21/Multiple_myeloma_%282%29_HE_stain.jpg/190px-Multiple_myeloma_%282%29_HE_stain.jpg" width="190" height="143" border="0" /></a></div>
</div>
</th>
</tr>
<tr style="line-height: 1;">
<td colspan="2" style="text-align:center;"><small><a href="/wiki/Bone_marrow" title="Bone marrow">Bone marrow</a> aspirate showing multiple myeloma under the microscope (<a href="/wiki/H%26E_stain" title="H&amp;E stain">H&amp;E stain</a>).</small></td>
</tr>
<tr>
<th><a href="/wiki/ICD" title="ICD" class="mw-redirect">ICD</a>-<a href="/wiki/List_of_ICD-10_codes" title="List of ICD-10 codes" class="mw-redirect">10</a></th>
<td><a href="/wiki/ICD-10_Chapter_C" title="ICD-10 Chapter C" class="mw-redirect">C</a><a href="http://www.who.int/classifications/apps/icd/icd10online/?gc81.htm+c900" class="external text" title="http://www.who.int/classifications/apps/icd/icd10online/?gc81.htm+c900" rel="nofollow">90.0</a></td>
</tr>
<tr>
<th><a href="/wiki/ICD" title="ICD" class="mw-redirect">ICD</a>-<a href="/wiki/List_of_ICD-9_codes" title="List of ICD-9 codes">9</a></th>
<td><a href="http://www.icd9data.com/getICD9Code.ashx?icd9=203.0" class="external text" title="http://www.icd9data.com/getICD9Code.ashx?icd9=203.0" rel="nofollow">203.0</a></td>
</tr>
<tr>
<th><a href="/wiki/International_Classification_of_Diseases_for_Oncology" title="International Classification of Diseases for Oncology">ICD-O:</a></th>
<td><a href="/wiki/ICD-O" title="ICD-O" class="mw-redirect">M</a><a href="http://www.progenetix.net/progenetix/I97323/" class="external text" title="http://www.progenetix.net/progenetix/I97323/" rel="nofollow">9732/3</a></td>
</tr>
<tr>
<th><a href="/wiki/OMIM" title="OMIM" class="mw-redirect">OMIM</a></th>
<td><a href="http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=254500" class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=254500" rel="nofollow">254500</a></td>
</tr>
<tr>
<th><a href="/wiki/Diseases_Database" title="Diseases Database">DiseasesDB</a></th>
<td><a href="http://www.diseasesdatabase.com/ddb8628.htm" class="external text" title="http://www.diseasesdatabase.com/ddb8628.htm" rel="nofollow">8628</a></td>
</tr>
<tr>
<th><a href="/wiki/MedlinePlus" title="MedlinePlus">MedlinePlus</a></th>
<td><a href="http://www.nlm.nih.gov/medlineplus/ency/article/000583.htm" class="external text" title="http://www.nlm.nih.gov/medlineplus/ency/article/000583.htm" rel="nofollow">000583</a></td>
</tr>
<tr>
<th><a href="/wiki/EMedicine" title="EMedicine">eMedicine</a></th>
<td><a href="http://www.emedicine.com/med/topic1521.htm" class="external text" title="http://www.emedicine.com/med/topic1521.htm" rel="nofollow">med/1521</a>&#160;</td>
</tr>
<tr>
<th><b><a href="/wiki/Medical_Subject_Headings" title="Medical Subject Headings">MeSH</a></b></th>
<td><a href="http://www.nlm.nih.gov/cgi/mesh/2009/MB_cgi?field=uid&amp;term=D009101" class="external text" title="http://www.nlm.nih.gov/cgi/mesh/2009/MB_cgi?field=uid&amp;term=D009101" rel="nofollow">D009101</a></td>
</tr>
</table>
<p><b>Multiple myeloma</b> (also known as <b>MM</b>, <b>myeloma</b>, <b>plasma cell myeloma</b>, or as <b>Kahler's disease</b> after <a href="/wiki/Otto_Kahler" title="Otto Kahler">Otto Kahler</a>) is a <a href="/wiki/Cancer" title="Cancer">cancer</a> of <a href="/wiki/Plasma_cell" title="Plasma cell">plasma cells</a>. These <a href="/wiki/Immune_system" title="Immune system">immune</a> cells are formed in bone marrow, are numerous in lymphatics and produce <a href="/wiki/Antibody" title="Antibody">antibodies</a>. Myeloma is regarded as incurable, but remissions may be induced with <a href="/wiki/Glucocorticoid" title="Glucocorticoid">steroids</a>, <a href="/wiki/Chemotherapy" title="Chemotherapy">chemotherapy</a>, <a href="/wiki/Thalidomide" title="Thalidomide">thalidomide</a> and <a href="/wiki/Stem_cell_transplant" title="Stem cell transplant" class="mw-redirect">stem cell transplants</a>. Myeloma is part of the broad group of diseases called <a href="/wiki/Hematological_malignancy" title="Hematological malignancy">hematological malignancies</a>.</p>
<table id="toc" class="toc" summary="Contents">
<tr>
<td>
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1"><a href="#Signs_and_symptoms"><span class="tocnumber">1</span> <span class="toctext">Signs and symptoms</span></a>
<ul>
<li class="toclevel-2"><a href="#Bone_pain"><span class="tocnumber">1.1</span> <span class="toctext">Bone pain</span></a></li>
<li class="toclevel-2"><a href="#Infection"><span class="tocnumber">1.2</span> <span class="toctext">Infection</span></a></li>
<li class="toclevel-2"><a href="#Renal_failure"><span class="tocnumber">1.3</span> <span class="toctext">Renal failure</span></a></li>
<li class="toclevel-2"><a href="#Anemia"><span class="tocnumber">1.4</span> <span class="toctext">Anemia</span></a></li>
<li class="toclevel-2"><a href="#Neurological_symptoms"><span class="tocnumber">1.5</span> <span class="toctext">Neurological symptoms</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Diagnosis"><span class="tocnumber">2</span> <span class="toctext">Diagnosis</span></a>
<ul>
<li class="toclevel-2"><a href="#Investigations"><span class="tocnumber">2.1</span> <span class="toctext">Investigations</span></a></li>
<li class="toclevel-2"><a href="#Workup"><span class="tocnumber">2.2</span> <span class="toctext">Workup</span></a></li>
<li class="toclevel-2"><a href="#Diagnostic_criteria"><span class="tocnumber">2.3</span> <span class="toctext">Diagnostic criteria</span></a></li>
<li class="toclevel-2"><a href="#Staging"><span class="tocnumber">2.4</span> <span class="toctext">Staging</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Pathophysiology"><span class="tocnumber">3</span> <span class="toctext">Pathophysiology</span></a></li>
<li class="toclevel-1"><a href="#Treatment"><span class="tocnumber">4</span> <span class="toctext">Treatment</span></a>
<ul>
<li class="toclevel-2"><a href="#Initial_therapy"><span class="tocnumber">4.1</span> <span class="toctext">Initial therapy</span></a></li>
<li class="toclevel-2"><a href="#Relapse"><span class="tocnumber">4.2</span> <span class="toctext">Relapse</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Prognosis"><span class="tocnumber">5</span> <span class="toctext">Prognosis</span></a></li>
<li class="toclevel-1"><a href="#Epidemiology"><span class="tocnumber">6</span> <span class="toctext">Epidemiology</span></a></li>
<li class="toclevel-1"><a href="#See_also"><span class="tocnumber">7</span> <span class="toctext">See also</span></a></li>
<li class="toclevel-1"><a href="#References"><span class="tocnumber">8</span> <span class="toctext">References</span></a></li>
<li class="toclevel-1"><a href="#External_links"><span class="tocnumber">9</span> <span class="toctext">External links</span></a></li>
</ul>
</td>
</tr>
</table>
<script type="text/javascript">
//<![CDATA[
 if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } 
//]]>
</script>
<p><a name="Signs_and_symptoms" id="Signs_and_symptoms"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Multiple_myeloma&amp;action=edit&amp;section=1" title="Edit section: Signs and symptoms">edit</a>]</span> <span class="mw-headline">Signs and symptoms</span></h2>
<p>Because many organs can be affected by myeloma, the symptoms and signs vary greatly. A <a href="/wiki/Mnemonic" title="Mnemonic">mnemonic</a> sometimes used to remember the common tetrad of multiple myeloma is <i>CRAB</i>: C = Calcium (elevated), R = Renal failure, A = Anemia, B = Bone lesions.<sup id="cite_ref-IMWG_0-0" class="reference"><a href="#cite_note-IMWG-0" title=""><span>[</span>1<span>]</span></a></sup> Myeloma has many possible symptoms, and all symptoms may be due to other causes. They are presented here in decreasing order of incidence.</p>
<p><a name="Bone_pain" id="Bone_pain"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Multiple_myeloma&amp;action=edit&amp;section=2" title="Edit section: Bone pain">edit</a>]</span> <span class="mw-headline">Bone pain</span></h3>
<p>Myeloma bone pain usually involves the spine and ribs, and worsens with activity. Persistent localized pain may indicate a pathological <a href="/wiki/Bone_fracture" title="Bone fracture">bone fracture</a>. Involvement of the vertebrae may lead to <a href="/wiki/Spinal_cord_compression" title="Spinal cord compression">spinal cord compression</a>. Myeloma bone disease is due to the release of RANKL by plasma cells and bone marrow stroma which binds to activatory RANK receptors on the osteoclast. These bone lesions are lytic in nature and are best seen in plain radiographs, which may show "punched-out" resorptive lesions. The breakdown of bone also leads to release of <a href="/wiki/Calcium" title="Calcium">calcium</a> into the blood, leading to <a href="/wiki/Hypercalcemia" title="Hypercalcemia" class="mw-redirect">hypercalcemia</a> and its associated symptoms.</p>
<p><a name="Infection" id="Infection"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Multiple_myeloma&amp;action=edit&amp;section=3" title="Edit section: Infection">edit</a>]</span> <span class="mw-headline">Infection</span></h3>
<p>The most common infections are <a href="/wiki/Pneumonia" title="Pneumonia">pneumonias</a> and <a href="/wiki/Pyelonephritis" title="Pyelonephritis">pyelonephritis</a>. Common pneumonia pathogens include <i><a href="/wiki/Streptococcus_pneumoniae" title="Streptococcus pneumoniae">S. pneumoniae</a></i>, <i><a href="/wiki/Staphylococcus_aureus" title="Staphylococcus aureus">S. aureus</a></i>, and <i><a href="/wiki/Klebsiella_pneumoniae" title="Klebsiella pneumoniae">K. pneumoniae</a></i>, while common pathogens causing pyelonephritis include <i><a href="/wiki/Escherichia_coli" title="Escherichia coli">E. coli</a></i> and other <a href="/wiki/Gram-negative" title="Gram-negative" class="mw-redirect">gram-negative</a> organisms. The greatest risk period for the occurrence of infection is in the initial few months after the start of chemotherapy.<sup id="cite_ref-pmid8033429_1-0" class="reference"><a href="#cite_note-pmid8033429-1" title=""><span>[</span>2<span>]</span></a></sup> The increased risk of infection is due to immune deficiency resulting from diffuse <a href="/wiki/Hypogammaglobulinemia" title="Hypogammaglobulinemia">hypogammaglobulinemia</a>, which is due to decreased production and increased destruction of normal <a href="/wiki/Antibody" title="Antibody">antibodies</a>. A selected group of patients may benefit from replacement immunoglobulin therapy to reduce the risk of infection.<sup id="cite_ref-pmid7730490_2-0" class="reference"><a href="#cite_note-pmid7730490-2" title=""><span>[</span>3<span>]</span></a></sup></p>
<p><a name="Renal_failure" id="Renal_failure"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Multiple_myeloma&amp;action=edit&amp;section=4" title="Edit section: Renal failure">edit</a>]</span> <span class="mw-headline">Renal failure</span></h3>
<p><a href="/wiki/Renal_failure" title="Renal failure">Renal failure</a> may develop both <a href="/wiki/Acute_renal_failure" title="Acute renal failure">acutely</a> and <a href="/wiki/Chronic_renal_failure" title="Chronic renal failure" class="mw-redirect">chronically</a>. It is commonly due to <a href="/wiki/Hypercalcemia" title="Hypercalcemia" class="mw-redirect">hypercalcemia</a> (see above). It may also be due to tubular damage from excretion of <a href="/wiki/Light_chain" title="Light chain">light chains</a>, also called <a href="/wiki/Bence_Jones_protein" title="Bence Jones protein">Bence Jones proteins</a>, which can manifest as the <a href="/wiki/Fanconi_syndrome" title="Fanconi syndrome">Fanconi syndrome</a> (type II <a href="/wiki/Renal_tubular_acidosis" title="Renal tubular acidosis">renal tubular acidosis</a>). Other causes include glomerular deposition of <a href="/wiki/Amyloid" title="Amyloid">amyloid</a>, <a href="/wiki/Hyperuricemia" title="Hyperuricemia">hyperuricemia</a>, recurrent infections (<a href="/wiki/Pyelonephritis" title="Pyelonephritis">pyelonephritis</a>), and local infiltration of tumor cells.</p>
<p><a name="Anemia" id="Anemia"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Multiple_myeloma&amp;action=edit&amp;section=5" title="Edit section: Anemia">edit</a>]</span> <span class="mw-headline">Anemia</span></h3>
<p>The <a href="/wiki/Anemia" title="Anemia">anemia</a> found in myeloma is usually normocytic and normochromic. It results from the replacement of normal bone marrow by infiltrating tumor cells and inhibition of normal red blood cell production (<a href="/wiki/Hematopoiesis" title="Hematopoiesis" class="mw-redirect">hematopoiesis</a>) by <a href="/wiki/Cytokines" title="Cytokines" class="mw-redirect">cytokines</a>.</p>
<p><a name="Neurological_symptoms" id="Neurological_symptoms"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Multiple_myeloma&amp;action=edit&amp;section=6" title="Edit section: Neurological symptoms">edit</a>]</span> <span class="mw-headline">Neurological symptoms</span></h3>
<p>Common problems are weakness, confusion and fatigue due to <a href="/wiki/Hypercalcemia" title="Hypercalcemia" class="mw-redirect">hypercalcemia</a>. <a href="/wiki/Headache" title="Headache">Headache</a>, visual changes and <a href="/wiki/Retinopathy" title="Retinopathy">retinopathy</a> may be the result of hyperviscosity of the blood depending on the properties of the <a href="/wiki/Paraprotein" title="Paraprotein">paraprotein</a>. Finally, there may be <a href="/wiki/Radicular_pain" title="Radicular pain">radicular pain</a>, loss of bowel or bladder control (due to involvement of <a href="/wiki/Spinal_cord" title="Spinal cord">spinal cord</a> leading to cord compression) or <a href="/wiki/Carpal_tunnel_syndrome" title="Carpal tunnel syndrome">carpal tunnel syndrome</a> and other <a href="/wiki/Neuropathies" title="Neuropathies" class="mw-redirect">neuropathies</a> (due to infiltration of <a href="/wiki/Peripheral_nerves" title="Peripheral nerves" class="mw-redirect">peripheral nerves</a> by <a href="/wiki/Amyloid" title="Amyloid">amyloid</a>). It may give rise to <a href="/wiki/Paraplegia" title="Paraplegia">paraplegia</a> in late presenting cases.</p>
<p><a name="Diagnosis" id="Diagnosis"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Multiple_myeloma&amp;action=edit&amp;section=7" title="Edit section: Diagnosis">edit</a>]</span> <span class="mw-headline">Diagnosis</span></h2>
<p><a name="Investigations" id="Investigations"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Multiple_myeloma&amp;action=edit&amp;section=8" title="Edit section: Investigations">edit</a>]</span> <span class="mw-headline">Investigations</span></h3>
<div class="thumb tright">
<div class="thumbinner" style="width:182px;"><a href="/wiki/File:Monoclonal_gammopathy_Multiple_Myeloma.png" class="image" title="Serum protein electrophoresis showing a paraprotein (peak in the gamma zone) in a patient with multiple myeloma."><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/thumb/d/d7/Monoclonal_gammopathy_Multiple_Myeloma.png/180px-Monoclonal_gammopathy_Multiple_Myeloma.png" width="180" height="73" border="0" class="thumbimage" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Monoclonal_gammopathy_Multiple_Myeloma.png" class="internal" title="Enlarge"><img src="/skins-1.5/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
Serum <a href="/wiki/Protein_electrophoresis" title="Protein electrophoresis">protein electrophoresis</a> showing a paraprotein (peak in the gamma zone) in a patient with multiple myeloma.</div>
</div>
</div>
<p>The presence of unexplained <a href="/wiki/Anemia" title="Anemia">anemia</a>, <a href="/wiki/Kidney" title="Kidney">kidney</a> dysfunction, a high <a href="/wiki/Erythrocyte_sedimentation_rate" title="Erythrocyte sedimentation rate">erythrocyte sedimentation rate</a> (ESR) and a high serum <a href="/wiki/Protein" title="Protein">protein</a> (especially raised <a href="/wiki/Immunoglobulin" title="Immunoglobulin" class="mw-redirect">immunoglobulin</a>) may prompt further testing. A <a href="/wiki/Medical_doctor" title="Medical doctor" class="mw-redirect">doctor</a> will request <a href="/wiki/Protein_electrophoresis" title="Protein electrophoresis">protein electrophoresis</a> of the blood and urine, which might show the presence of a <a href="/wiki/Paraprotein" title="Paraprotein">paraprotein</a> (monoclonal protein, or M protein) band, with or without reduction of the other (normal) immunoglobulins (known as immune paresis). One type of paraprotein is the <a href="/wiki/Bence_Jones_protein" title="Bence Jones protein">Bence Jones protein</a> which is a urinary paraprotein composed of free light chains (see below). Quantitative measurements of the paraprotein are necessary to establish a diagnosis and to monitor the disease. The paraprotein is an abnormal <a href="/wiki/Immunoglobulin" title="Immunoglobulin" class="mw-redirect">immunoglobulin</a> produced by the tumor clone. Very rarely, the myeloma is <i>nonsecretory</i> (not producing immunoglobulins).</p>
<p>In theory, multiple myeloma can produce all classes of immunoglobulin, but IgG paraproteins are most common, followed by IgA and IgM. IgD and IgE myeloma are very rare. In addition, light and or heavy chains (the building blocks of antibodies) may be secreted in isolation: κ- or λ-light chains or any of the five types of heavy chains (α-, γ-, δ-, ε- or μ-heavy chains).</p>
<p>Additional findings include: a raised <a href="/wiki/Calcium" title="Calcium">calcium</a> (when <a href="/wiki/Osteoclasts" title="Osteoclasts" class="mw-redirect">osteoclasts</a> are breaking down bone, releasing calcium into the bloodstream), raised serum creatinine due to reduced <a href="/wiki/Renal_function" title="Renal function">renal function</a>, which may be due to paraprotein deposition in the <a href="/wiki/Kidney" title="Kidney">kidney</a>.</p>
<p><a name="Workup" id="Workup"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Multiple_myeloma&amp;action=edit&amp;section=9" title="Edit section: Workup">edit</a>]</span> <span class="mw-headline">Workup</span></h3>
<div class="thumb tright">
<div class="thumbinner" style="width:182px;"><a href="/wiki/File:Multiple_myeloma_skull_CT_arrows.PNG" class="image" title="A 59 year-old patient presented with a left facial droop and a known history of multiple myeloma. A CT of the brain was performed looking for a cerebral cause. The brain appeared normal. Close inspection revealed a lytic lesion in the left temporal bone (right side of image), and focused reconstructions of the petrous temporal bones confirmed a lytic lesion involving the mastoid segment of the facial nerve canal. Red arrows: lesion; green arrow: normal contralateral facial nerve canal. The lytic lesion was one of many in the skull and is consistent with a myeloma deposit."><img alt="" src="http://upload.wikimedia.org/wikipedia/commons/thumb/6/6c/Multiple_myeloma_skull_CT_arrows.PNG/180px-Multiple_myeloma_skull_CT_arrows.PNG" width="180" height="81" border="0" class="thumbimage" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Multiple_myeloma_skull_CT_arrows.PNG" class="internal" title="Enlarge"><img src="/skins-1.5/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
A 59 year-old patient presented with a left facial droop and a known history of multiple myeloma. A <a href="/wiki/Computed_tomography" title="Computed tomography">CT</a> of the brain was performed looking for a <a href="/wiki/Cerebrum" title="Cerebrum">cerebral</a> cause. The brain appeared normal. Close inspection revealed a lytic lesion in the left <a href="/wiki/Temporal_bone" title="Temporal bone">temporal bone</a> (right side of image), and focused reconstructions of the petrous temporal bones confirmed a lytic lesion involving the mastoid segment of the <a href="/wiki/Facial_nerve" title="Facial nerve">facial nerve</a> canal. Red arrows: lesion; green arrow: normal contralateral facial nerve canal. The lytic lesion was one of many in the skull and is consistent with a myeloma deposit.</div>
</div>
</div>
<p>The workup of suspected multiple myeloma includes a <a href="/wiki/Skeletal_survey" title="Skeletal survey">skeletal survey</a>. This is a series of <a href="/wiki/X-ray" title="X-ray">X-rays</a> of the skull, axial skeleton and proximal long bones. Myeloma activity sometimes appear as "lytic lesions" (with local disappearance of normal bone due to resorption), and on the skull X-ray as "punched-out lesions" (pepper pot skull). <a href="/wiki/Magnetic_resonance_imaging" title="Magnetic resonance imaging">Magnetic resonance imaging</a> (MRI) is more sensitive than simple X-ray in the detection of lytic lesions, and may supersede skeletal survey, especially when vertebral disease is suspected. Occasionally a <a href="/wiki/CT_scan" title="CT scan" class="mw-redirect">CT scan</a> is performed to measure the size of soft tissue plasmacytomas. <a href="/wiki/Bone_scan" title="Bone scan">Bone scans</a> are typically not of any additional value in the workup of myeloma patients.</p>
<p>A <a href="/wiki/Bone_marrow_biopsy" title="Bone marrow biopsy" class="mw-redirect">bone marrow biopsy</a> is usually performed to estimate the percentage of bone marrow occupied by plasma cells. This percentage is used in the diagnostic criteria for myeloma. <a href="/wiki/Immunohistochemistry" title="Immunohistochemistry">Immunohistochemistry</a> (staining particular cell types using antibodies against surface proteins) can detect plasma cells which express immunoglobulin in the cytoplasm but usually not on the surface; myeloma cells are typically <a href="/wiki/CD56" title="CD56" class="mw-redirect">CD56</a>, <a href="/wiki/CD38" title="CD38">CD38</a>, <a href="/wiki/CD138" title="CD138" class="mw-redirect">CD138</a> positive and <a href="/wiki/CD19" title="CD19">CD19</a> and <a href="/wiki/CD45" title="CD45" class="mw-redirect">CD45</a> negative.<sup id="cite_ref-IMWG_0-1" class="reference"><a href="#cite_note-IMWG-0" title=""><span>[</span>1<span>]</span></a></sup> <a href="/wiki/Cytogenetics" title="Cytogenetics">Cytogenetics</a> may also be performed in myeloma for prognostic purposes.</p>
<p>Other useful laboratory tests include quantitative measurement of <a href="/wiki/IgA" title="IgA" class="mw-redirect">IgA</a>, <a href="/wiki/IgG" title="IgG" class="mw-redirect">IgG</a>, <a href="/wiki/IgM" title="IgM" class="mw-redirect">IgM</a> (<a href="/wiki/Immunoglobulin" title="Immunoglobulin" class="mw-redirect">immunoglobulins</a>) to look for immune paresis, and β2-microglobulin which provides prognostic information. On peripheral blood smear the rouleaux formation of red blood cells is commonly seen.</p>
<p>The recent introduction of a commercial immunoassay for measurement of free light chains potentially offers an improvement in monitoring disease progression and response to treatment, particularly where the paraprotein is difficult to measure accurately by electrophoresis (for example in light chain myeloma, or where the paraprotein level is very low). Initial research also suggests that measurement of free light chains may also be used, in conjunction with other markers, for assessment of the risk of progression from <a href="/wiki/Monoclonal_gammopathy_of_undetermined_significance" title="Monoclonal gammopathy of undetermined significance">monoclonal gammopathy of undetermined significance</a> (MGUS) to multiple myeloma.<sup class="noprint Template-Fact"><span title="This claim needs references to reliable sources&#160;since February 2007" style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed">citation needed</a></i>]</span></sup></p>
<p>This assay, the serum free light chain assay, has recently been recommended by the International Myeloma Working Group for the screening, diagnosis, prognosis, and monitoring of plasma cell dyscrasias.</p>
<p><a name="Diagnostic_criteria" id="Diagnostic_criteria"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Multiple_myeloma&amp;action=edit&amp;section=10" title="Edit section: Diagnostic criteria">edit</a>]</span> <span class="mw-headline">Diagnostic criteria</span></h3>
<p>In 2003, the International Myeloma Working Group<sup id="cite_ref-IMWG_0-2" class="reference"><a href="#cite_note-IMWG-0" title=""><span>[</span>1<span>]</span></a></sup> agreed on diagnostic criteria for symptomatic myeloma, asymptomatic myeloma and <a href="/wiki/Monoclonal_gammopathy_of_undetermined_significance" title="Monoclonal gammopathy of undetermined significance">MGUS</a> (monoclonal gammopathy of undetermined significance):</p>
<ul>
<li>Symptomatic myeloma:
<ol>
<li>Clonal plasma cells &gt;10% on <a href="/wiki/Bone_marrow" title="Bone marrow">bone marrow</a> <a href="/wiki/Biopsy" title="Biopsy">biopsy</a> or (in any quantity) in a biopsy from other tissues (<a href="/wiki/Plasmacytoma" title="Plasmacytoma">plasmacytoma</a>)</li>
<li>A <a href="/wiki/Monoclonal" title="Monoclonal">monoclonal</a> protein (<a href="/wiki/Paraprotein" title="Paraprotein">paraprotein</a>) in either <a href="/wiki/Blood_plasma" title="Blood plasma">serum</a> or <a href="/wiki/Urine" title="Urine">urine</a></li>
<li>Evidence of end-organ damage (<i>related organ or tissue impairment</i>, ROTI):
<ul>
<li><a href="/wiki/Hypercalcemia" title="Hypercalcemia" class="mw-redirect">Hypercalcemia</a> (corrected calcium &gt;2.75 mmol/L)</li>
<li><a href="/wiki/Renal_insufficiency" title="Renal insufficiency" class="mw-redirect">Renal insufficiency</a> attributable to myeloma</li>
<li><a href="/wiki/Anemia" title="Anemia">Anemia</a> (hemoglobin &lt;10 g/dL)</li>
<li>Bone <a href="/wiki/Lesions" title="Lesions" class="mw-redirect">lesions</a> (lytic lesions or <a href="/wiki/Osteoporosis" title="Osteoporosis">osteoporosis</a> with compression fractures)</li>
<li>Frequent severe <a href="/wiki/Infections" title="Infections" class="mw-redirect">infections</a> (&gt;2 a year)</li>
<li><a href="/wiki/Amyloidosis" title="Amyloidosis">Amyloidosis</a> of other organs</li>
<li><a href="/wiki/Hyperviscosity_syndrome" title="Hyperviscosity syndrome">Hyperviscosity syndrome</a></li>
</ul>
</li>
</ol>
</li>
<li>Asymptomatic myeloma:
<ol>
<li>Serum paraprotein &gt;30 g/L AND/OR</li>
<li>Clonal plasma cells &gt;10% on bone marrow biopsy AND</li>
<li>NO myeloma-related organ or tissue impairment</li>
</ol>
</li>
<li>Monoclonal gammopathy of undetermined significance (MGUS):
<ol>
<li>Serum paraprotein &lt;30 g/L AND</li>
<li>Clonal plasma cells &lt;10% on bone marrow biopsy AND</li>
<li>NO myeloma-related organ or tissue impairment</li>
</ol>
</li>
</ul>
<p>Related conditions include <i>solitary <a href="/wiki/Plasmacytoma" title="Plasmacytoma">plasmacytoma</a></i> (a single tumor of plasma cells, typically treated with irradiation), <i>plasma cell <a href="/wiki/Dyscrasia" title="Dyscrasia">dyscrasia</a></i> (where only the antibodies produce symptoms, e.g. AL <a href="/wiki/Amyloid" title="Amyloid">amyloidosis</a>), and <a href="/wiki/POEMS_syndrome" title="POEMS syndrome">POEMS syndrome</a> (peripheral neuropathy, organomegaly, endocrinopathy, monoclonal plasma cell disorder, skin changes).</p>
<p><a name="Staging" id="Staging"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Multiple_myeloma&amp;action=edit&amp;section=11" title="Edit section: Staging">edit</a>]</span> <span class="mw-headline">Staging</span></h3>
<dl>
<dt>International Staging System</dt>
</dl>
<p>The International Staging System (ISS) for myeloma was published by the International Myeloma Working Group in 2005:<sup id="cite_ref-ISS_3-0" class="reference"><a href="#cite_note-ISS-3" title=""><span>[</span>4<span>]</span></a></sup></p>
<ul>
<li>Stage I: <a href="/wiki/Beta-2-microglobulin" title="Beta-2-microglobulin" class="mw-redirect">β<sub>2</sub>-microglobulin</a> (β2M) &lt; 3.5 mg/L, <a href="/wiki/Serum_albumin" title="Serum albumin">albumin</a> &gt;= 3.5 g/dL</li>
<li>Stage II: β2M &lt; 3.5 and albumin &lt; 3.5; or β2M &gt;= 3.5 and &lt; 5.5</li>
<li>Stage III: β2M &gt;= 5.5</li>
</ul>
<dl>
<dt>Durie-Salmon staging system</dt>
</dl>
<p>First published in 1975, the Durie-Salmon staging system <sup id="cite_ref-Salmon_4-0" class="reference"><a href="#cite_note-Salmon-4" title=""><span>[</span>5<span>]</span></a></sup> is still in use, but has largely been superseded by the simpler ISS:</p>
<ul>
<li>stage 1: all of
<ul>
<li>Hb &gt; 10g/dL</li>
<li>normal calcium</li>
<li>Skeletal survey: normal or single plasmacytoma or osteoporosis</li>
<li>Serum paraprotein level &lt; 5 g/dL if IgG, &lt; 3 g/dL if IgA</li>
<li>Urinary light chain excretion &lt; 4 g/24h</li>
</ul>
</li>
<li>stage 2: fulfilling the criteria of neither 1 nor 3</li>
<li>stage 3: one or more of
<ul>
<li>Hb &lt; 8.5g/dL</li>
<li>high calcium &gt; 12mg/dL</li>
<li>Skeletal survey: 3 or more lytic bone lesions</li>
<li>Serum paraprotein &gt;7g/dL if IgG, &gt; 5 g/dL if IgA</li>
<li>Urinary light chain excretion &gt; 12g/24h</li>
</ul>
</li>
</ul>
<p>Stages 1, 2 and 3 of the Durie-Salmon staging system can be divided into A or B depending on serum creatinine:</p>
<ul>
<li>A: serum creatinine &lt; 2mg/dL (&lt; 177 umol/L)</li>
<li>B: serum creatinine &gt; 2mg/dL (&gt; 177 umol/L)</li>
</ul>
<p><a name="Pathophysiology" id="Pathophysiology"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Multiple_myeloma&amp;action=edit&amp;section=12" title="Edit section: Pathophysiology">edit</a>]</span> <span class="mw-headline">Pathophysiology</span></h2>
<p>Multiple myeloma develops in post-germinal center <a href="/wiki/B_lymphocytes" title="B lymphocytes" class="mw-redirect">B lymphocytes</a>. A <a href="/wiki/Chromosomal_translocation" title="Chromosomal translocation">chromosomal translocation</a> between the immunoglobulin <a href="/wiki/Heavy_chain" title="Heavy chain">heavy chain</a> gene (on the fourteenth <a href="/wiki/Chromosome" title="Chromosome">chromosome</a>, locus 14q32) and an <a href="/wiki/Oncogene" title="Oncogene">oncogene</a> (often 11q13, 4p16.3, 6p21, 16q23 and 20q11<sup id="cite_ref-Kyle_5-0" class="reference"><a href="#cite_note-Kyle-5" title=""><span>[</span>6<span>]</span></a></sup>) is frequently observed in patients with multiple myeloma. This mutation results in dysregulation of the oncogene which is thought to be an important initiating event in the pathogenesis of myeloma. The result is proliferation of a plasma cell clone and genomic instability that leads to further mutations and translocations. The chromosome 14 abnormality is observed in about 50% of all cases of myeloma. Deletion of (parts of) the thirteenth chromosome is also observed in about 50% of cases.</p>
<p>Production of <a href="/wiki/Cytokine" title="Cytokine">cytokines</a> (especially <a href="/wiki/Interleukin_6" title="Interleukin 6">IL-6</a>) by the plasma cells causes much of their localised damage, such as <a href="/wiki/Osteoporosis" title="Osteoporosis">osteoporosis</a>, and creates a microenvironment in which the malignant cells thrive. <a href="/wiki/Angiogenesis" title="Angiogenesis">Angiogenesis</a> (the attraction of new blood vessels) is increased.</p>
<p>The produced antibodies are deposited in various organs, leading to renal failure, polyneuropathy and various other myeloma-associated symptoms.</p>
<p><a name="Treatment" id="Treatment"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Multiple_myeloma&amp;action=edit&amp;section=13" title="Edit section: Treatment">edit</a>]</span> <span class="mw-headline">Treatment</span></h2>
<p>Treatment for multiple myeloma is focused on disease containment and suppression. If the disease is completely asymptomatic (i.e. there is a paraprotein and an abnormal bone marrow population but no end-organ damage), treatment may be deferred.</p>
<p>In addition to direct treatment of the plasma cell proliferation, <a href="/wiki/Bisphosphonate" title="Bisphosphonate">bisphosphonates</a> (e.g. <a href="/wiki/Pamidronate" title="Pamidronate" class="mw-redirect">pamidronate</a> or <a href="/wiki/Zoledronic_acid" title="Zoledronic acid">zoledronic acid</a>) are routinely administered to prevent fractures and <a href="/wiki/Erythropoietin" title="Erythropoietin">erythropoietin</a> to treat anemia.</p>
<p><a name="Initial_therapy" id="Initial_therapy"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Multiple_myeloma&amp;action=edit&amp;section=14" title="Edit section: Initial therapy">edit</a>]</span> <span class="mw-headline">Initial therapy</span></h3>
<p>Initial treatment of multiple myeloma depends on the patient’s age and comorbidities. In recent years, high-dose chemotherapy with hematopoietic stem-cell transplantation has become the preferred treatment for patients under the age of 65. Prior to stem-cell transplantation, these patients receive an initial course of induction chemotherapy. The most common induction regimens used today are <a href="/wiki/Thalidomide" title="Thalidomide">thalidomide</a>–<a href="/wiki/Dexamethasone" title="Dexamethasone">dexamethasone</a>, <a href="/wiki/Bortezomib" title="Bortezomib">bortezomib</a> based regimens, and <a href="/wiki/Lenalidomide" title="Lenalidomide">lenalidomide</a>–dexamethasone. <sup id="cite_ref-6" class="reference"><a href="#cite_note-6" title=""><span>[</span>7<span>]</span></a></sup> <a href="/wiki/Autologous_stem_cell_transplantation" title="Autologous stem cell transplantation">Autologous stem cell transplantation</a>, the transplantation of a patient’s own stem cells after chemotherapy, is the most common type of stem cell transplantation for multiple myeloma. It is not curative, but does prolong overall survival. <a href="/wiki/Allogeneic_stem_cell_transplantation" title="Allogeneic stem cell transplantation">Allogeneic stem cell transplantation</a>, the transplantation of a healthy person’s stem cells into the affected patient, has the potential for a cure, but is only available to a small percentage of patients. <sup id="cite_ref-Kyle_5-1" class="reference"><a href="#cite_note-Kyle-5" title=""><span>[</span>6<span>]</span></a></sup> Furthermore, there is a 5-10% treatment-associated mortality rate.</p>
<p>Patients over age 65 and patients with significant concurrent illness often cannot tolerate stem cell transplantation. For these patients, the standard of care has been chemotherapy with <a href="/wiki/Melphalan" title="Melphalan">melphalan</a> and prednisone. Recent studies among this population<sup id="cite_ref-7" class="reference"><a href="#cite_note-7" title=""><span>[</span>8<span>]</span></a></sup> suggest improved outcomes with new chemotherapy regimens. Treatment with bortezomib, melphalan and prednisone had an estimated overall survival of 83% at 30 months, lenalidomide plus low-dose dexamethasone an 82% survival at 2 years and melphalan, prednisone and lenalidomide had a 90% survival at 2 years. Head-to-head studies comparing these regimens have not been performed.<sup id="cite_ref-8" class="reference"><a href="#cite_note-8" title=""><span>[</span>9<span>]</span></a></sup></p>
<p><a name="Relapse" id="Relapse"></a></p>
<h3><span class="editsection">[<a href="/w/index.php?title=Multiple_myeloma&amp;action=edit&amp;section=15" title="Edit section: Relapse">edit</a>]</span> <span class="mw-headline">Relapse</span></h3>
<p>The natural history of myeloma is of relapse following treatment. Depending on the patient's condition, the prior treatment modalities used and the duration of remission, options for relapsed disease include re-treatment with the original agent, use of other agents (such as melphalan, cyclophosphamide, thalidomide or dexamethasone, alone or in combination), and a second autologous stem cell transplant.</p>
<p>Later in the course of the disease, "treatment resistance" occurs. This may be a reversible effect,<sup id="cite_ref-Kyle_5-2" class="reference"><a href="#cite_note-Kyle-5" title=""><span>[</span>6<span>]</span></a></sup> and some new treatment modalities may re-sensitize the tumor to standard therapy. For patients with <i>relapsed disease</i>, <a href="/wiki/Bortezomib" title="Bortezomib">bortezomib</a> (or Velcade) is a recent addition to the therapeutic arsenal, especially as second line therapy, since 2005. Bortezomib is a <a href="/wiki/Proteasome" title="Proteasome">proteasome</a> inhibitor. Finally, <a href="/wiki/Lenalidomide" title="Lenalidomide">lenalidomide</a> (or Revlimid), a less toxic thalidomide analog, is showing promise for treating myeloma.</p>
<p>Renal failure in multiple myeloma can be <a href="/wiki/Acute_renal_failure" title="Acute renal failure">acute</a> (reversible) or <a href="/wiki/Chronic_renal_failure" title="Chronic renal failure" class="mw-redirect">chronic</a> (irreversible). Acute renal failure typically resolves when the calcium and paraprotein levels are brought under control. Treatment of chronic renal failure is dependent on the type of renal failure and may involve <a href="/wiki/Dialysis" title="Dialysis">dialysis</a>.</p>
<p><a name="Prognosis" id="Prognosis"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Multiple_myeloma&amp;action=edit&amp;section=16" title="Edit section: Prognosis">edit</a>]</span> <span class="mw-headline">Prognosis</span></h2>
<p>The <a href="#Staging" title="">International Staging System</a> can help to predict survival, with a median survival of 62 months for stage 1 disease, 45 months for stage 2 disease, and 29 months for stage 3 disease.<sup id="cite_ref-ISS_3-1" class="reference"><a href="#cite_note-ISS-3" title=""><span>[</span>4<span>]</span></a></sup></p>
<p><a href="/wiki/Cytogenetic" title="Cytogenetic" class="mw-redirect">Cytogenetic</a> analysis of myeloma cells may be of <a href="/wiki/Prognosis" title="Prognosis">prognostic value</a>, with deletion of chromosome 13, non-hyperdiploidy and the balanced translocations t(4;14) and t(14;16) conferring a poorer prognosis. The 11q13 and 6p21 cytogenetic abnormalities are associated with a better prognosis.</p>
<p>Prognostic markers such as these are always generated by retrospective analyses, and it is likely that new treatment developments will improve the outlook for those with traditionally "poor-risk" disease.</p>
<p><a name="Epidemiology" id="Epidemiology"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Multiple_myeloma&amp;action=edit&amp;section=17" title="Edit section: Epidemiology">edit</a>]</span> <span class="mw-headline">Epidemiology</span></h2>
<p>There are approximately 45,000 people in the <a href="/wiki/United_States" title="United States">United States</a> living with multiple myeloma, and the <a href="/wiki/American_Cancer_Society" title="American Cancer Society">American Cancer Society</a> estimates that approximately 14,600 new cases of myeloma are diagnosed each year in the United States. It follows from here that the average survival at diagnosis is about three years.</p>
<p>Multiple myeloma is the second most prevalent blood cancer (10%) after <a href="/wiki/Non-Hodgkin%27s_lymphoma" title="Non-Hodgkin's lymphoma" class="mw-redirect">non-Hodgkin's lymphoma</a>. It represents approximately 1% of all cancers and 2% of all cancer deaths. Although the peak age of onset of multiple myeloma is 65 to 70 years of age, recent statistics indicate both increasing incidence and earlier age of onset.</p>
<p>Multiple myeloma affects slightly more men than women. African Americans and Native Pacific Islanders have the highest reported incidence of this disease in the United States and Asians the lowest. Results of a recent study found the incidence of myeloma to be 9.5 cases per 100,000 African Americans and 4.1 cases per 100,000 Caucasian Americans. Among African Americans, myeloma is one of the top 10 leading causes of cancer death.</p>
<p><a name="See_also" id="See_also"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Multiple_myeloma&amp;action=edit&amp;section=18" title="Edit section: See also">edit</a>]</span> <span class="mw-headline">See also</span></h2>
<ul>
<li><a href="/wiki/Waldenstr%C3%B6m_macroglobulinemia" title="Waldenström macroglobulinemia" class="mw-redirect">Waldenström macroglobulinemia</a></li>
<li><a href="/wiki/Plasma_cell_leukemia" title="Plasma cell leukemia">Plasma cell leukemia</a></li>
<li><a href="/wiki/Multiple_Myeloma_Research_Consortium" title="Multiple Myeloma Research Consortium">Multiple Myeloma Research Consortium</a></li>
<li><a href="/wiki/Multiple_Myeloma_Research_Foundation" title="Multiple Myeloma Research Foundation">Multiple Myeloma Research Foundation</a></li>
<li><a href="/wiki/MM_Support_Network" title="MM Support Network" class="mw-redirect">MM Support Network</a></li>
<li><a href="/wiki/Monoclonal_antibodies" title="Monoclonal antibodies">Monoclonal antibodies</a></li>
</ul>
<p><a name="References" id="References"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Multiple_myeloma&amp;action=edit&amp;section=19" title="Edit section: References">edit</a>]</span> <span class="mw-headline">References</span></h2>
<div class="references-small references-column-count references-column-count-2" style="-moz-column-count:2; column-count:2;">
<ol class="references">
<li id="cite_note-IMWG-0">^ <a href="#cite_ref-IMWG_0-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-IMWG_0-1" title=""><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-IMWG_0-2" title=""><sup><i><b>c</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFInternational_Myeloma_Working_Group2003">International Myeloma Working Group (2003). "Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group". <i>Br. J. Haematol.</i> <b>121</b> (5): 749–57. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1046%2Fj.1365-2141.2003.04355.x" class="external text" title="http://dx.doi.org/10.1046%2Fj.1365-2141.2003.04355.x" rel="nofollow">10.1046/j.1365-2141.2003.04355.x</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/12780789" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/12780789">PMID 12780789</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Criteria+for+the+classification+of+monoclonal+gammopathies%2C+multiple+myeloma+and+related+disorders%3A+a+report+of+the+International+Myeloma+Working+Group&amp;rft.jtitle=Br.+J.+Haematol.&amp;rft.aulast=International+Myeloma+Working+Group&amp;rft.au=International+Myeloma+Working+Group&amp;rft.date=2003&amp;rft.volume=121&amp;rft.issue=5&amp;rft.pages=749%E2%80%9357&amp;rft_id=info:doi/10.1046%2Fj.1365-2141.2003.04355.x&amp;rft_id=info:pmid/12780789&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_myeloma"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-pmid8033429-1"><b><a href="#cite_ref-pmid8033429_1-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFChapel_HM.2C_Lee_M1994">Chapel HM, Lee M (1994). "The use of intravenous immune globulin in multiple myeloma". <i>Clin. Exp. Immunol.</i> <b>97 Suppl 1</b>: 21–4. <a href="http://www.ncbi.nlm.nih.gov/pubmed/8033429" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/8033429">PMID 8033429</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=The+use+of+intravenous+immune+globulin+in+multiple+myeloma&amp;rft.jtitle=Clin.+Exp.+Immunol.&amp;rft.aulast=Chapel+HM%2C+Lee+M&amp;rft.au=Chapel+HM%2C+Lee+M&amp;rft.date=1994&amp;rft.volume=97+Suppl+1&amp;rft.pages=21%E2%80%934&amp;rft_id=info:pmid/8033429&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_myeloma"><span style="display: none;">&#160;</span></span> Full text at <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>: <a href="http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&amp;artid=1550368" class="external text" title="http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&amp;artid=1550368" rel="nofollow">1550368</a></li>
<li id="cite_note-pmid7730490-2"><b><a href="#cite_ref-pmid7730490_2-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFHargreaves_RM.2C_Lea_JR.2C_Griffiths_H.2C_.27.27et_al.27.271995">Hargreaves RM, Lea JR, Griffiths H, <i>et al</i> (1995). "<a href="http://jcp.bmj.com/cgi/reprint/48/3/260" class="external text" title="http://jcp.bmj.com/cgi/reprint/48/3/260" rel="nofollow">Immunological factors and risk of infection in plateau phase myeloma</a>" (PDF). <i>J. Clin. Pathol.</i> <b>48</b> (3): 260–6. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1136%2Fjcp.48.3.260" class="external text" title="http://dx.doi.org/10.1136%2Fjcp.48.3.260" rel="nofollow">10.1136/jcp.48.3.260</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/7730490" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/7730490">PMID 7730490</a><span class="printonly">. <a href="http://jcp.bmj.com/cgi/reprint/48/3/260" class="external free" title="http://jcp.bmj.com/cgi/reprint/48/3/260" rel="nofollow">http://jcp.bmj.com/cgi/reprint/48/3/260</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Immunological+factors+and+risk+of+infection+in+plateau+phase+myeloma&amp;rft.jtitle=J.+Clin.+Pathol.&amp;rft.aulast=Hargreaves+RM%2C+Lea+JR%2C+Griffiths+H%2C+%27%27et+al%27%27&amp;rft.au=Hargreaves+RM%2C+Lea+JR%2C+Griffiths+H%2C+%27%27et+al%27%27&amp;rft.date=1995&amp;rft.volume=48&amp;rft.issue=3&amp;rft.pages=260%E2%80%936&amp;rft_id=info:doi/10.1136%2Fjcp.48.3.260&amp;rft_id=info:pmid/7730490&amp;rft_id=http%3A%2F%2Fjcp.bmj.com%2Fcgi%2Freprint%2F48%2F3%2F260&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_myeloma"><span style="display: none;">&#160;</span></span> Full text at <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>: <a href="http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&amp;artid=502468" class="external text" title="http://www.pubmedcentral.gov/articlerender.fcgi?tool=pmcentrez&amp;artid=502468" rel="nofollow">502468</a></li>
<li id="cite_note-ISS-3">^ <a href="#cite_ref-ISS_3-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-ISS_3-1" title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFGreipp_PR.2C_San_Miguel_J.2C_Durie_BG.2C_.27.27et_al.27.272005">Greipp PR, San Miguel J, Durie BG, <i>et al</i> (2005). "<a href="http://jco.ascopubs.org/cgi/content/full/23/15/3412" class="external text" title="http://jco.ascopubs.org/cgi/content/full/23/15/3412" rel="nofollow">International staging system for multiple myeloma</a>". <i>J. Clin. Oncol.</i> <b>23</b> (15): 3412–20. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1200%2FJCO.2005.04.242" class="external text" title="http://dx.doi.org/10.1200%2FJCO.2005.04.242" rel="nofollow">10.1200/JCO.2005.04.242</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15809451" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15809451">PMID 15809451</a><span class="printonly">. <a href="http://jco.ascopubs.org/cgi/content/full/23/15/3412" class="external free" title="http://jco.ascopubs.org/cgi/content/full/23/15/3412" rel="nofollow">http://jco.ascopubs.org/cgi/content/full/23/15/3412</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=International+staging+system+for+multiple+myeloma&amp;rft.jtitle=J.+Clin.+Oncol.&amp;rft.aulast=Greipp+PR%2C+San+Miguel+J%2C+Durie+BG%2C+%27%27et+al%27%27&amp;rft.au=Greipp+PR%2C+San+Miguel+J%2C+Durie+BG%2C+%27%27et+al%27%27&amp;rft.date=2005&amp;rft.volume=23&amp;rft.issue=15&amp;rft.pages=3412%E2%80%9320&amp;rft_id=info:doi/10.1200%2FJCO.2005.04.242&amp;rft_id=info:pmid/15809451&amp;rft_id=http%3A%2F%2Fjco.ascopubs.org%2Fcgi%2Fcontent%2Ffull%2F23%2F15%2F3412&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_myeloma"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Salmon-4"><b><a href="#cite_ref-Salmon_4-0" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFDurie_BG.2C_Salmon_SE1975">Durie BG, Salmon SE (1975). "A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival". <i>Cancer</i> <b>36</b> (3): 842–54. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1002%2F1097-0142%28197509%2936%3A3%3C842%3A%3AAID-CNCR2820360303%3E3.0.CO%3B2-U" class="external text" title="http://dx.doi.org/10.1002%2F1097-0142%28197509%2936%3A3%3C842%3A%3AAID-CNCR2820360303%3E3.0.CO%3B2-U" rel="nofollow">10.1002/1097-0142(197509)36:3&lt;842::AID-CNCR2820360303&gt;3.0.CO;2-U</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/1182674" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/1182674">PMID 1182674</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=A+clinical+staging+system+for+multiple+myeloma.+Correlation+of+measured+myeloma+cell+mass+with+presenting+clinical+features%2C+response+to+treatment%2C+and+survival&amp;rft.jtitle=Cancer&amp;rft.aulast=Durie+BG%2C+Salmon+SE&amp;rft.au=Durie+BG%2C+Salmon+SE&amp;rft.date=1975&amp;rft.volume=36&amp;rft.issue=3&amp;rft.pages=842%E2%80%9354&amp;rft_id=info:doi/10.1002%2F1097-0142%28197509%2936%3A3%3C842%3A%3AAID-CNCR2820360303%3E3.0.CO%3B2-U&amp;rft_id=info:pmid/1182674&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_myeloma"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-Kyle-5">^ <a href="#cite_ref-Kyle_5-0" title=""><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Kyle_5-1" title=""><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Kyle_5-2" title=""><sup><i><b>c</b></i></sup></a> <cite style="font-style:normal" class="" id="CITEREFKyle_RA.2C_Rajkumar_SV2004">Kyle RA, Rajkumar SV (2004). "Multiple myeloma". <i>N. Engl. J. Med.</i> <b>351</b> (18): 1860–73. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1056%2FNEJMra041875" class="external text" title="http://dx.doi.org/10.1056%2FNEJMra041875" rel="nofollow">10.1056/NEJMra041875</a></span>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15509819" class="external" title="http://www.ncbi.nlm.nih.gov/pubmed/15509819">PMID 15509819</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Multiple+myeloma&amp;rft.jtitle=N.+Engl.+J.+Med.&amp;rft.aulast=Kyle+RA%2C+Rajkumar+SV&amp;rft.au=Kyle+RA%2C+Rajkumar+SV&amp;rft.date=2004&amp;rft.volume=351&amp;rft.issue=18&amp;rft.pages=1860%E2%80%9373&amp;rft_id=info:doi/10.1056%2FNEJMra041875&amp;rft_id=info:pmid/15509819&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_myeloma"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-6"><b><a href="#cite_ref-6" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFKyle.2C_R.A..2C_Rajkumar.2C_S.V.2008">Kyle, R.A., Rajkumar, S.V. (2008). "<a href="http://bloodjournal.hematologylibrary.org/cgi/content/full/111/6/2962#F4" class="external text" title="http://bloodjournal.hematologylibrary.org/cgi/content/full/111/6/2962#F4" rel="nofollow">Multiple myeloma</a>". <i>Blood.</i> <b>111</b> (6): 2962–2972. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1182%2Fblood-2007-10-078022" class="external text" title="http://dx.doi.org/10.1182%2Fblood-2007-10-078022" rel="nofollow">10.1182/blood-2007-10-078022</a></span><span class="printonly">. <a href="http://bloodjournal.hematologylibrary.org/cgi/content/full/111/6/2962#F4" class="external free" title="http://bloodjournal.hematologylibrary.org/cgi/content/full/111/6/2962#F4" rel="nofollow">http://bloodjournal.hematologylibrary.org/cgi/content/full/111/6/2962#F4</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Multiple+myeloma&amp;rft.jtitle=Blood.&amp;rft.aulast=Kyle%2C+R.A.%2C+Rajkumar%2C+S.V.&amp;rft.au=Kyle%2C+R.A.%2C+Rajkumar%2C+S.V.&amp;rft.date=2008&amp;rft.volume=111&amp;rft.issue=6&amp;rft.pages=2962%E2%80%932972&amp;rft_id=info:doi/10.1182%2Fblood-2007-10-078022&amp;rft_id=http%3A%2F%2Fbloodjournal.hematologylibrary.org%2Fcgi%2Fcontent%2Ffull%2F111%2F6%2F2962%23F4&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_myeloma"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-7"><b><a href="#cite_ref-7" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFSan_Miguel.2C_J.F._et_al2008">San Miguel, J.F. et al (2008). "Bortezomib plus Melphalan and Prednisone for Initial Treatment of Multiple Myeloma". <i>New England Journal of Medicine</i> <b>359</b> (9): 906–917. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1056%2FNEJMoa0801479" class="external text" title="http://dx.doi.org/10.1056%2FNEJMoa0801479" rel="nofollow">10.1056/NEJMoa0801479</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Bortezomib+plus+Melphalan+and+Prednisone+for+Initial+Treatment+of+Multiple+Myeloma&amp;rft.jtitle=New+England+Journal+of+Medicine&amp;rft.aulast=San+Miguel%2C+J.F.+et+al&amp;rft.au=San+Miguel%2C+J.F.+et+al&amp;rft.date=2008&amp;rft.volume=359&amp;rft.issue=9&amp;rft.pages=906%E2%80%93917&amp;rft_id=info:doi/10.1056%2FNEJMoa0801479&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_myeloma"><span style="display: none;">&#160;</span></span></li>
<li id="cite_note-8"><b><a href="#cite_ref-8" title="">^</a></b> <cite style="font-style:normal" class="" id="CITEREFDurie.2C_B.G.M.2008">Durie, B.G.M. (2008). "Treatment of Myeloma - Are We Making Progress?". <i>New England Journal of Medicine</i> <b>359</b> (9): 964–966. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<span class="neverexpand"><a href="http://dx.doi.org/10.1056%2FNEJMe0805176" class="external text" title="http://dx.doi.org/10.1056%2FNEJMe0805176" rel="nofollow">10.1056/NEJMe0805176</a></span>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Treatment+of+Myeloma+-+Are+We+Making+Progress%3F&amp;rft.jtitle=New+England+Journal+of+Medicine&amp;rft.aulast=Durie%2C+B.G.M.&amp;rft.au=Durie%2C+B.G.M.&amp;rft.date=2008&amp;rft.volume=359&amp;rft.issue=9&amp;rft.pages=964%E2%80%93966&amp;rft_id=info:doi/10.1056%2FNEJMe0805176&amp;rfr_id=info:sid/en.wikipedia.org:Multiple_myeloma"><span style="display: none;">&#160;</span></span></li>
</ol>
</div>
<p><a name="External_links" id="External_links"></a></p>
<h2><span class="editsection">[<a href="/w/index.php?title=Multiple_myeloma&amp;action=edit&amp;section=20" title="Edit section: External links">edit</a>]</span> <span class="mw-headline">External links</span></h2>
<ul>
<li><a href="http://www.myelomaforums.com" class="external text" title="http://www.myelomaforums.com" rel="nofollow">Myeloma Forums</a></li>
<li><a href="http://www.myeloma.org.uk" class="external text" title="http://www.myeloma.org.uk" rel="nofollow">Myeloma UK</a></li>
<li><a href="http://www.myeloma.org" class="external text" title="http://www.myeloma.org" rel="nofollow">International Myeloma Foundation</a></li>
<li><a href="http://www.qxmd.com/hematology/Prognosis-In-Multiple-Myeloma-International-Staging-System-ISS.php" class="external text" title="http://www.qxmd.com/hematology/Prognosis-In-Multiple-Myeloma-International-Staging-System-ISS.php" rel="nofollow">Online Myeloma ISS scoring tool</a></li>
<li><a href="http://www.multiplemyeloma.org" class="external text" title="http://www.multiplemyeloma.org" rel="nofollow">Multiple Myeloma Research Foundation</a></li>
<li><a href="http://www.leukemia-lymphoma.org/all_page?item_id=7032" class="external text" title="http://www.leukemia-lymphoma.org/all_page?item_id=7032" rel="nofollow">The Leukemia &amp; Lymphoma Society's Myeloma Page</a></li>
<li><a href="http://www.mayoclinic.org/multiple-myeloma/" class="external text" title="http://www.mayoclinic.org/multiple-myeloma/" rel="nofollow">Overview</a> at <a href="/wiki/Mayo_Clinic" title="Mayo Clinic">Mayo Clinic</a></li>
</ul>
<table class="navbox" cellspacing="0" style=";">
<tr>
<td style="padding:2px;">
<table cellspacing="0" class="nowraplinks collapsible autocollapse" style="width:100%;background:transparent;color:inherit;;">
<tr>
<th style=";background:Silver" colspan="2" class="navbox-title">
<div style="float:left; width:6em;text-align:left;">
<div class="noprint plainlinksneverexpand navbar" style="background:none; padding:0; font-weight:normal;;background:Silver;border:none;; font-size:xx-small;"><a href="/wiki/Template:Lymphoid_malignancy" title="Template:Lymphoid malignancy"><span title="View this template" style=";background:Silver;border:none;">v</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="/wiki/Template_talk:Lymphoid_malignancy" title="Template talk:Lymphoid malignancy"><span title="Discussion about this template" style=";background:Silver;border:none;">d</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="http://en.wikipedia.org/w/index.php?title=Template:Lymphoid_malignancy&amp;action=edit" class="external text" title="http://en.wikipedia.org/w/index.php?title=Template:Lymphoid_malignancy&amp;action=edit" rel="nofollow"><span title="Edit this template" style=";background:Silver;border:none;;">e</span></a></div>
</div>
<span style="font-size:110%;"><a href="/wiki/Hematological_malignancy" title="Hematological malignancy">Hematological malignancy</a>/<a href="/wiki/Leukemia" title="Leukemia">leukemia</a> histology (<a href="/wiki/International_Classification_of_Diseases_for_Oncology" title="International Classification of Diseases for Oncology">ICD-O</a> 9590-9989, <a href="/wiki/ICD-10_Chapter_II:_Neoplasms#.28C81-C96.29_Malignant_neoplasms.2C_stated_or_presumed_to_be_primary.2C_of_lymphoid.2C_haematopoietic_and_related_tissue" title="ICD-10 Chapter II: Neoplasms">C81-C96</a>, <a href="/wiki/List_of_ICD-9_codes_140-239:_Neoplasms#malignant_neoplasm_of_lymphatic_and_hematopoietic_tissue_.28200-208.29" title="List of ICD-9 codes 140-239: Neoplasms" class="mw-redirect">200-208</a>)<br />
<a href="/wiki/Lymphoid" title="Lymphoid" class="mw-redirect">Lymphoid</a>/<a href="/wiki/Lymphoproliferative_disorders" title="Lymphoproliferative disorders">Lymphoproliferative</a>, <a href="/wiki/Lymphoma" title="Lymphoma">Lymphomas</a>/<a href="/wiki/Lymphoid_leukemia" title="Lymphoid leukemia">Lymphoid leukemias</a> (9590-9739, 9800-9839)</span></th>
</tr>
<tr style="height:2px;">
<td></td>
</tr>
<tr>
<td colspan="2" style="width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: MistyRose;">
<div style="padding:0em 0.75em;"><a href="/wiki/Lymphoma#Mature_B_cell_neoplasms" title="Lymphoma">B cell</a><br />
(<a href="/wiki/B-cell_lymphoma" title="B-cell lymphoma">lymphoma</a>,<br />
<a href="/wiki/B-cell_leukemia" title="B-cell leukemia">leukemia</a>)<br />
(most <a href="/wiki/CD19" title="CD19">CD19</a>, <a href="/wiki/CD20" title="CD20">CD20</a>)</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: MistyRose;">
<div style="padding:0em 0.75em;">By development/<br />
marker</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: MistyRose;">
<div style="padding:0em 0.75em;"><a href="/wiki/Terminal_deoxynucleotidyl_transferase" title="Terminal deoxynucleotidyl transferase">TdT+</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Acute_lymphoblastic_leukemia" title="Acute lymphoblastic leukemia">ALL</a> (<a href="/wiki/Precursor_B_acute_lymphoblastic_leukemia/lymphoma" title="Precursor B acute lymphoblastic leukemia/lymphoma">Precursor B acute lymphoblastic leukemia/lymphoma</a>)</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: MistyRose;">
<div style="padding:0em 0.75em;"><a href="/wiki/CD5_(protein)" title="CD5 (protein)">CD5</a>+</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><i><a href="/wiki/Naive_B_cell" title="Naive B cell">naive B cell</a></i> (<a href="/wiki/B-cell_chronic_lymphocytic_leukemia" title="B-cell chronic lymphocytic leukemia">CLL/SLL</a>)<br />
<i><a href="/wiki/Mantle_zone" title="Mantle zone">mantle zone</a></i> (<a href="/wiki/Mantle_cell_lymphoma" title="Mantle cell lymphoma">Mantle cell</a>)</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: MistyRose;">
<div style="padding:0em 0.75em;"><a href="/wiki/CD22" title="CD22">CD22</a>+</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/B-cell_prolymphocytic_leukemia" title="B-cell prolymphocytic leukemia">Prolymphocytic</a><span style="font-weight:bold;">&#160;·</span> <i><a href="/wiki/CD11c" title="CD11c">CD11c</a></i> (<a href="/wiki/Hairy_cell_leukemia" title="Hairy cell leukemia">Hairy cell leukemia</a>)</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: MistyRose;">
<div style="padding:0em 0.75em;"><a href="/wiki/CD79A" title="CD79A">CD79a</a>+</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><i><a href="/wiki/Germinal_center" title="Germinal center">germinal center</a>/<a href="/wiki/Follicular_B_cell" title="Follicular B cell">follicular B cell</a></i> (<a href="/wiki/Follicular_lymphoma" title="Follicular lymphoma">Follicular</a>, <a href="/wiki/Burkitt%27s_lymphoma" title="Burkitt's lymphoma">Burkitt's</a>, <a href="/wiki/Diffuse_large_B_cell_lymphoma" title="Diffuse large B cell lymphoma">GCB-DLBCL</a>)<br />
<i><a href="/wiki/Marginal_zone_B-cell_lymphoma" title="Marginal zone B-cell lymphoma">marginal zone</a>/<a href="/wiki/Marginal-zone_B_cell" title="Marginal-zone B cell">marginal-zone B cell</a></i> (<a href="/wiki/Splenic_marginal_zone_lymphoma" title="Splenic marginal zone lymphoma">Splenic marginal zone</a>, <a href="/wiki/MALT_lymphoma" title="MALT lymphoma">MALT</a>, <a href="/wiki/Nodal_marginal_zone_B_cell_lymphoma" title="Nodal marginal zone B cell lymphoma">Nodal marginal zone</a>)</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: MistyRose;">
<div style="padding:0em 0.75em;"><a href="/wiki/Reed-Sternberg_cell" title="Reed-Sternberg cell">RS</a> (<a href="/wiki/CD15" title="CD15">CD15</a>+,<a href="/wiki/CD30" title="CD30">CD30</a>+)</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Hodgkin%27s_lymphoma" title="Hodgkin's lymphoma">Classic Hodgkin's lymphoma</a> (<a href="/wiki/Nodular_sclerosis" title="Nodular sclerosis">Nodular sclerosis</a>)<span style="font-weight:bold;">&#160;·</span> <i><a href="/wiki/CD20" title="CD20">CD20</a></i> (<a href="/wiki/Nodular_lymphocyte_predominant_Hodgkin%27s_lymphoma" title="Nodular lymphocyte predominant Hodgkin's lymphoma">Nodular lymphocyte predominant Hodgkin's lymphoma</a>)</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: MistyRose;">
<div style="padding:0em 0.75em;"><a href="/wiki/Plasma_cell_dyscrasia" title="Plasma cell dyscrasia">PCDs</a>/<a href="/wiki/Paraproteinemia" title="Paraproteinemia">PP</a><br />
(<a href="/wiki/CD38" title="CD38">CD38</a>+/<a href="/wiki/CD138" title="CD138" class="mw-redirect">CD138</a>+)</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Plasmacytoma" title="Plasmacytoma">Plasmacytoma</a><span style="font-weight:bold;">&#160;·</span> <strong class="selflink">Multiple myeloma</strong> (<a href="/wiki/Plasma_cell_leukemia" title="Plasma cell leukemia">Plasma cell leukemia</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Monoclonal_gammopathy_of_undetermined_significance" title="Monoclonal gammopathy of undetermined significance">MGUS</a><span style="font-weight:bold;">&#160;·</span> <i><a href="/wiki/Immunoglobulin_M" title="Immunoglobulin M">IgM</a></i> (<a href="/wiki/Waldenstr%C3%B6m%27s_macroglobulinemia" title="Waldenström's macroglobulinemia">Waldenström's macroglobulinemia</a>)<span style="font-weight:bold;">&#160;·</span> <i><a href="/wiki/Immunoglobulin_heavy_chain" title="Immunoglobulin heavy chain">heavy chain</a></i> (<a href="/wiki/Heavy_chain_disease" title="Heavy chain disease">Heavy chain disease</a>)<span style="font-weight:bold;">&#160;·</span> <i><a href="/wiki/Immunoglobulin_light_chain" title="Immunoglobulin light chain">light chain</a></i> (<a href="/wiki/AL_amyloidosis" title="AL amyloidosis">Primary amyloidosis</a>)</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: MistyRose;">
<div style="padding:0em 0.75em;">By infection</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><i><a href="/wiki/Kaposi%27s_sarcoma-associated_herpesvirus" title="Kaposi's sarcoma-associated herpesvirus">KSHV</a></i> (<a href="/wiki/Primary_effusion_lymphoma" title="Primary effusion lymphoma">Primary effusion</a>)<span style="font-weight:bold;">&#160;·</span> <i><a href="/wiki/Epstein-Barr_virus" title="Epstein-Barr virus">EBV</a></i> (<a href="/wiki/Lymphomatoid_granulomatosis" title="Lymphomatoid granulomatosis">Lymphomatoid granulomatosis</a>, <a href="/wiki/Post-transplant_lymphoproliferative_disorder" title="Post-transplant lymphoproliferative disorder">Post-transplant lymphoproliferative disorder</a>)<span style="font-weight:bold;">&#160;·</span> <i><a href="/wiki/HIV" title="HIV">HIV</a></i> (<a href="/wiki/AIDS-related_lymphoma" title="AIDS-related lymphoma">AIDS-related lymphoma</a>)<span style="font-weight:bold;">&#160;·</span> <i><a href="/wiki/Helicobacter_pylori" title="Helicobacter pylori">Helicobacter pylori</a></i> (<a href="/wiki/MALT_lymphoma" title="MALT lymphoma">MALT lymphoma</a>)</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: MistyRose;">
<div style="padding:0em 0.75em;"><a href="/wiki/Lymphoma#Mature_T_cell_and_natural_killer_.28NK.29_cell_neoplasms" title="Lymphoma">T/NK</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: MistyRose;">
<div style="padding:0em 0.75em;"><a href="/wiki/T_cell" title="T cell">T cell</a><br />
(<a href="/wiki/T-cell_lymphoma" title="T-cell lymphoma">lymphoma</a>,<br />
<a href="/wiki/T-cell_leukemia" title="T-cell leukemia">leukemia</a>)<br />
(most <a href="/wiki/CD3_(immunology)" title="CD3 (immunology)">CD3</a>, <a href="/wiki/CD4" title="CD4">CD4</a>, <a href="/wiki/CD8" title="CD8">CD8</a>)</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: MistyRose;">
<div style="padding:0em 0.75em;">By development/<br />
marker</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Terminal_deoxynucleotidyl_transferase" title="Terminal deoxynucleotidyl transferase">TdT+</a>: <a href="/wiki/Acute_lymphoblastic_leukemia" title="Acute lymphoblastic leukemia">ALL</a> (<a href="/wiki/Precursor_T_acute_lymphoblastic_leukemia/lymphoma" title="Precursor T acute lymphoblastic leukemia/lymphoma">Precursor T acute lymphoblastic leukemia/lymphoma</a>)
<p><i><a href="/wiki/Prolymphocyte" title="Prolymphocyte">prolymphocyte</a></i> (<a href="/wiki/T-cell_prolymphocytic_leukemia" title="T-cell prolymphocytic leukemia">Prolymphocytic</a>)</p>
<i><a href="/wiki/CD30" title="CD30">CD30+</a></i> (<a href="/wiki/Anaplastic_large_cell_lymphoma" title="Anaplastic large cell lymphoma">Anaplastic large cell</a>, <a href="/wiki/Lymphomatoid_papulosis" title="Lymphomatoid papulosis">Lymphomatoid papulosis</a>)</div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: MistyRose;">
<div style="padding:0em 0.75em;">By location/<a href="/wiki/Peripheral_T-cell_lymphoma" title="Peripheral T-cell lymphoma">peripheral</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Cutaneous_T_cell_lymphoma" title="Cutaneous T cell lymphoma">Cutaneous</a> (<a href="/wiki/Mycosis_fungoides" title="Mycosis fungoides">Mycosis fungoides</a>, <a href="/wiki/S%C3%A9zary%27s_disease" title="Sézary's disease">Sézary's disease</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Hepatosplenic_T-cell_lymphoma" title="Hepatosplenic T-cell lymphoma">Hepatosplenic</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Angioimmunoblastic_T-cell_lymphoma" title="Angioimmunoblastic T-cell lymphoma">Angioimmunoblastic</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Enteropathy-associated_T-cell_lymphoma" title="Enteropathy-associated T-cell lymphoma">Enteropathy-associated T-cell lymphoma</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: MistyRose;">
<div style="padding:0em 0.75em;">By infection</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><i><a href="/wiki/Human_T-lymphotropic_virus_1" title="Human T-lymphotropic virus 1">HTLV-1</a></i> (<a href="/wiki/Adult_T-cell_leukemia/lymphoma" title="Adult T-cell leukemia/lymphoma">Adult T-cell leukemia/lymphoma</a>)</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: MistyRose;">
<div style="padding:0em 0.75em;"><a href="/wiki/Lymphoma#Mature_T_cell_and_natural_killer_.28NK.29_cell_neoplasms" title="Lymphoma">NK cell</a>/<br />
(most <a href="/wiki/CD56" title="CD56" class="mw-redirect">CD56</a>)</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Aggressive_NK-cell_leukemia" title="Aggressive NK-cell leukemia">Aggressive NK-cell leukemia</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Blastic_NK_cell_lymphoma" title="Blastic NK cell lymphoma">Blastic NK cell lymphoma</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: MistyRose;">
<div style="padding:0em 0.75em;">T or NK</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><i><a href="/wiki/Epstein-Barr_virus" title="Epstein-Barr virus">EBV</a></i> (<a href="/wiki/Extranodal_NK-T-cell_lymphoma" title="Extranodal NK-T-cell lymphoma">Extranodal NK-T-cell lymphoma</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Large_granular_lymphocytic_leukemia" title="Large granular lymphocytic leukemia">Large granular lymphocytic leukemia</a></div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: MistyRose;">
<div style="padding:0em 0.75em;">Lymphoid+myeloid</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Acute_biphenotypic_leukaemia" title="Acute biphenotypic leukaemia">Acute biphenotypic leukaemia</a></div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td colspan="2" style="width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><i>See also <a href="/wiki/Template:Lymphatic_disease" title="Template:Lymphatic disease">lymphatic disease</a>, <a href="/wiki/Template:Myeloid_malignancy" title="Template:Myeloid malignancy">myeloid malignancy</a></i></div>
</td>
</tr>
</table>
</td>
</tr>
</table>
<table class="navbox" cellspacing="0" style=";">
<tr>
<td style="padding:2px;">
<table cellspacing="0" class="nowraplinks collapsible autocollapse" style="width:100%;background:transparent;color:inherit;;">
<tr>
<th style=";background:Silver" colspan="2" class="navbox-title">
<div style="float:left; width:6em;text-align:left;">
<div class="noprint plainlinksneverexpand navbar" style="background:none; padding:0; font-weight:normal;;background:Silver;border:none;; font-size:xx-small;"><a href="/wiki/Template:Chromosomal_abnormalities" title="Template:Chromosomal abnormalities"><span title="View this template" style=";background:Silver;border:none;">v</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="/w/index.php?title=Template_talk:Chromosomal_abnormalities&amp;action=edit&amp;redlink=1" class="new" title="Template talk:Chromosomal abnormalities (page does not exist)"><span title="Discussion about this template" style=";background:Silver;border:none;">d</span></a>&#160;<span style="font-size:80%;">•</span>&#160;<a href="http://en.wikipedia.org/w/index.php?title=Template:Chromosomal_abnormalities&amp;action=edit" class="external text" title="http://en.wikipedia.org/w/index.php?title=Template:Chromosomal_abnormalities&amp;action=edit" rel="nofollow"><span title="Edit this template" style=";background:Silver;border:none;;">e</span></a></div>
</div>
<span style="font-size:110%;"><a href="/wiki/Pathology" title="Pathology">Pathology</a>: <a href="/wiki/Chromosome_abnormalities" title="Chromosome abnormalities" class="mw-redirect">chromosome abnormalities</a> (<a href="/wiki/ICD-10_Chapter_Q#Q90-Q99_-_Chromosomal_abnormalities.2C_not_elsewhere_classified" title="ICD-10 Chapter Q" class="mw-redirect">Q90-Q99</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/List_of_ICD-9_codes_740-759:_Congenital_anomalies#Other" title="List of ICD-9 codes 740-759: Congenital anomalies" class="mw-redirect">758</a>)</span></th>
</tr>
<tr style="height:2px;">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background-color: LightGray;"><a href="/wiki/Autosomal" title="Autosomal" class="mw-redirect">Autosomal</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: LightGray;">
<div style="padding:0em 0.75em;"><a href="/wiki/Trisomy" title="Trisomy">Trisomies</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Down_syndrome" title="Down syndrome">Down syndrome</a> (<a href="/wiki/Chromosome_21_(human)" title="Chromosome 21 (human)">21</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Edwards_syndrome" title="Edwards syndrome">Edwards syndrome</a> (<a href="/wiki/Chromosome_18_(human)" title="Chromosome 18 (human)">18</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Patau_syndrome" title="Patau syndrome">Patau syndrome</a> (<a href="/wiki/Chromosome_13_(human)" title="Chromosome 13 (human)">13</a>)<br />
<a href="/wiki/Trisomy_9" title="Trisomy 9">Trisomy 9</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Warkany_syndrome_2" title="Warkany syndrome 2">Warkany syndrome 2</a> (<a href="/wiki/Chromosome_8_(human)" title="Chromosome 8 (human)">8</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Trisomy_22" title="Trisomy 22">Trisomy 22</a>/<a href="/wiki/Cat_eye_syndrome" title="Cat eye syndrome">Cat eye syndrome</a> (<a href="/wiki/Chromosome_22_(human)" title="Chromosome 22 (human)">22</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Trisomy_16" title="Trisomy 16">Trisomy 16</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: LightGray;">
<div style="padding:0em 0.75em;"><a href="/wiki/Monosomy" title="Monosomy">Monosomies</a>/<a href="/wiki/Deletion_(genetics)" title="Deletion (genetics)">deletions</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Wolf-Hirschhorn_syndrome" title="Wolf-Hirschhorn syndrome">Wolf-Hirschhorn syndrome</a> (<a href="/wiki/Chromosome_4_(human)" title="Chromosome 4 (human)">4</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Cri_du_chat" title="Cri du chat">Cri du chat</a>/<a href="/wiki/Chromosome_5q_deletion_syndrome" title="Chromosome 5q deletion syndrome">Chromosome 5q deletion syndrome</a> (<a href="/wiki/Chromosome_5_(human)" title="Chromosome 5 (human)">5</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Williams_syndrome" title="Williams syndrome">Williams syndrome</a> (<a href="/wiki/Chromosome_7_(human)" title="Chromosome 7 (human)">7</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Jacobsen_syndrome" title="Jacobsen syndrome">Jacobsen syndrome</a> (<a href="/wiki/Chromosome_11_(human)" title="Chromosome 11 (human)">11</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Miller-Dieker_syndrome" title="Miller-Dieker syndrome">Miller-Dieker syndrome</a>/<a href="/wiki/Smith-Magenis_syndrome" title="Smith-Magenis syndrome">Smith-Magenis syndrome</a> (<a href="/wiki/Chromosome_17_(human)" title="Chromosome 17 (human)">17</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/22q11.2_deletion_syndrome" title="22q11.2 deletion syndrome">22q11.2 deletion syndrome</a> (<a href="/wiki/Chromosome_22_(human)" title="Chromosome 22 (human)">22</a>)<br />
<i><a href="/wiki/Genomic_imprinting" title="Genomic imprinting">genomic imprinting</a></i> (<a href="/wiki/Angelman_syndrome" title="Angelman syndrome">Angelman syndrome</a>/<a href="/wiki/Prader-Willi_syndrome" title="Prader-Willi syndrome">Prader-Willi syndrome</a> (<a href="/wiki/Chromosome_15_(human)" title="Chromosome 15 (human)">15</a>))</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background-color: LightGray;"><a href="/wiki/X_chromosome" title="X chromosome">X</a>/<a href="/wiki/Y_chromosome" title="Y chromosome">Y</a> linked</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: LightGray;">
<div style="padding:0em 0.75em;"><a href="/wiki/Monosomy" title="Monosomy">Monosomy</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Turner_syndrome" title="Turner syndrome">Turner syndrome (XO)</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: LightGray;">
<div style="padding:0em 0.75em;"><a href="/wiki/Trisomy" title="Trisomy">Trisomy</a>/<a href="/wiki/Tetrasomy" title="Tetrasomy">Tetrasomy</a><br />
<a href="/wiki/Aneuploidy" title="Aneuploidy">other karyotypes</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Klinefelter%27s_syndrome" title="Klinefelter's syndrome">Klinefelter's syndrome (47,XXY)</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/XXYY_syndrome" title="XXYY syndrome">48,XXYY</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/49_XXXXY_syndrome" title="49 XXXXY syndrome">49,XXXXY</a>
<p><a href="/wiki/Triple_X_syndrome" title="Triple X syndrome">Triple X syndrome (47,XXX)</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/48,_XXXX" title="48, XXXX">48,XXXX</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/49,_XXXXX" title="49, XXXXX">49,XXXXX</a></p>
<a href="/wiki/XYY_syndrome" title="XYY syndrome">47,XYY</a></div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background-color: LightGray;"><a href="/wiki/Chromosomal_translocation" title="Chromosomal translocation">Translocations</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: LightGray;">
<div style="padding:0em 0.75em;"><a href="/wiki/Leukemia" title="Leukemia">Leukemia</a>/<a href="/wiki/Lymphoma" title="Lymphoma">lymphoma</a></div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"></div>
<table cellspacing="0" class="nowraplinks navbox-subgroup" style="width:100%;;;;">
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: LightGray;">
<div style="padding:0em 0.75em;">Lymphoid</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Burkitt%27s_lymphoma" title="Burkitt's lymphoma">Burkitt's lymphoma</a> t(8 <a href="/wiki/Myc" title="Myc">MYC</a>;14 <a href="/wiki/IGH" title="IGH" class="mw-redirect">IGH</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Follicular_lymphoma" title="Follicular lymphoma">Follicular lymphoma</a> t(14 <a href="/wiki/IGH" title="IGH" class="mw-redirect">IGH</a>;18 <a href="/wiki/Bcl-2" title="Bcl-2">BCL2</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Mantle_cell_lymphoma" title="Mantle cell lymphoma">Mantle cell lymphoma</a>/<strong class="selflink">Multiple myeloma</strong> t(11 <a href="/wiki/Cyclin_D1" title="Cyclin D1">CCND1</a>:14 <a href="/wiki/IGH" title="IGH" class="mw-redirect">IGH</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Anaplastic_large_cell_lymphoma" title="Anaplastic large cell lymphoma">Anaplastic large cell lymphoma</a> t(2 <a href="/wiki/Anaplastic_lymphoma_kinase" title="Anaplastic lymphoma kinase">ALK</a>;5 <a href="/wiki/NPM1" title="NPM1">NPM1</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Acute_lymphoblastic_leukemia" title="Acute lymphoblastic leukemia">Acute lymphoblastic leukemia</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: LightGray;">
<div style="padding:0em 0.75em;">Myeloid</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Philadelphia_chromosome" title="Philadelphia chromosome">Philadelphia chromosome</a> t(9 <a href="/wiki/Abl_gene" title="Abl gene">ABL</a>; 22 <a href="/wiki/BCR_gene" title="BCR gene">BCR</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Acute_myeloblastic_leukemia_with_maturation" title="Acute myeloblastic leukemia with maturation">Acute myeloblastic leukemia with maturation</a> t(8 <a href="/wiki/RUNX1T1" title="RUNX1T1">RUNX1T1</a>;21 <a href="/wiki/RUNX1" title="RUNX1">RUNX1</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Acute_promyelocytic_leukemia" title="Acute promyelocytic leukemia">Acute promyelocytic leukemia</a> t(15 <a href="/wiki/Promyelocytic_leukemia_protein" title="Promyelocytic leukemia protein">PML</a>,17 <a href="/wiki/Retinoic_acid_receptor_alpha" title="Retinoic acid receptor alpha">RARA</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Acute_megakaryoblastic_leukemia" title="Acute megakaryoblastic leukemia">Acute megakaryoblastic leukemia</a> t(1 <a href="/wiki/RBM15" title="RBM15">RBM15</a>;22 <a href="/wiki/MKL1" title="MKL1">MKL1</a>)</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";padding-left:0em;padding-right:0em;background-color: LightGray;">
<div style="padding:0em 0.75em;">Other</div>
</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Ewing%27s_sarcoma" title="Ewing's sarcoma">Ewing's sarcoma</a> t(11 <a href="/wiki/FLI1" title="FLI1">FLI1</a>; 22 <a href="/wiki/Ewing_sarcoma_breakpoint_region_1" title="Ewing sarcoma breakpoint region 1">EWS</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Synovial_sarcoma" title="Synovial sarcoma">Synovial sarcoma</a> t(x <a href="/wiki/SYT" title="SYT" class="mw-redirect">SYT</a>;18 <a href="/wiki/Synovial_sarcoma,_X_breakpoint" title="Synovial sarcoma, X breakpoint">SSX</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Dermatofibrosarcoma_protuberans" title="Dermatofibrosarcoma protuberans">Dermatofibrosarcoma protuberans</a> t(17 <a href="/wiki/Collagen,_type_I,_alpha_1" title="Collagen, type I, alpha 1">COL1A1</a>;22 <a href="/wiki/PDGFB" title="PDGFB">PDGFB</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Myxoid_liposarcoma" title="Myxoid liposarcoma">Myxoid liposarcoma</a> t(12 <a href="/wiki/DNA_damage-inducible_transcript_3" title="DNA damage-inducible transcript 3">DDIT3</a>; 16 <a href="/wiki/FUS" title="FUS">FUS</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Desmoplastic_small_round_cell_tumor" title="Desmoplastic small round cell tumor">Desmoplastic small round cell tumor</a> t(11 <a href="/wiki/WT1" title="WT1">WT1</a>; 22 <a href="/wiki/Ewing_sarcoma_breakpoint_region_1" title="Ewing sarcoma breakpoint region 1">EWS</a>)<span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Alveolar_rhabdomyosarcoma" title="Alveolar rhabdomyosarcoma">Alveolar rhabdomyosarcoma</a> t(2 <a href="/wiki/PAX3" title="PAX3">PAX3</a>; 13 <a href="/wiki/FOXO1" title="FOXO1">FOXO1</a>) t (1 <a href="/wiki/PAX7" title="PAX7">PAX7</a>; 13 <a href="/wiki/FOXO1" title="FOXO1">FOXO1</a>)</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background-color: LightGray;"><a href="/wiki/Gonadal_dysgenesis" title="Gonadal dysgenesis">Gonadal dysgenesis</a></td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-odd">
<div style="padding:0em 0.25em"><a href="/wiki/Mixed_gonadal_dysgenesis" title="Mixed gonadal dysgenesis">Mixed gonadal dysgenesis</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/XX_gonadal_dysgenesis" title="XX gonadal dysgenesis">XX gonadal dysgenesis</a></div>
</td>
</tr>
<tr style="height:2px">
<td></td>
</tr>
<tr>
<td class="navbox-group" style=";background-color: LightGray;">Other</td>
<td style="text-align:left;border-left:2px solid #fdfdfd;width:100%;padding:0px;;;" class="navbox-list navbox-even">
<div style="padding:0em 0.25em"><a href="/wiki/Fragile_X_syndrome" title="Fragile X syndrome">Fragile X syndrome</a><span style="font-weight:bold;">&#160;·</span> <a href="/wiki/Uniparental_disomy" title="Uniparental disomy">Uniparental disomy</a></div>
</td>
</tr>
</table>
</td>
</tr>
</table>


<!-- 
NewPP limit report
Preprocessor node count: 9000/1000000
Post-expand include size: 221895/2048000 bytes
Template argument size: 142143/2048000 bytes
Expensive parser function count: 1/500
-->

<!-- Saved in parser cache with key enwiki:pcache:idhash:292137-0!1!0!default!!en!2 and timestamp 20090404053339 -->
<div class="printfooter">
Retrieved from "<a href="http://en.wikipedia.org/wiki/Multiple_myeloma">http://en.wikipedia.org/wiki/Multiple_myeloma</a>"</div>
			<div id='catlinks' class='catlinks'><div id="mw-normal-catlinks"><a href="/wiki/Special:Categories" title="Special:Categories">Categories</a>:&#32;<span dir='ltr'><a href="/wiki/Category:Hematology" title="Category:Hematology">Hematology</a></span> | <span dir='ltr'><a href="/wiki/Category:Types_of_cancer" title="Category:Types of cancer">Types of cancer</a></span></div><div id="mw-hidden-catlinks" class="mw-hidden-cats-hidden">Hidden categories:&#32;<span dir='ltr'><a href="/wiki/Category:All_articles_with_unsourced_statements" title="Category:All articles with unsourced statements">All articles with unsourced statements</a></span> | <span dir='ltr'><a href="/wiki/Category:Articles_with_unsourced_statements_since_February_2007" title="Category:Articles with unsourced statements since February 2007">Articles with unsourced statements since February 2007</a></span></div></div>			<!-- end content -->
						<div class="visualClear"></div>
		</div>
	</div>
		</div>
		<div id="column-one">
	<div id="p-cactions" class="portlet">
		<h5>Views</h5>
		<div class="pBody">
			<ul>
	
				 <li id="ca-nstab-main" class="selected"><a href="/wiki/Multiple_myeloma" title="View the content page [c]" accesskey="c">Article</a></li>
				 <li id="ca-talk"><a href="/wiki/Talk:Multiple_myeloma" title="Discussion about the content page [t]" accesskey="t">Discussion</a></li>
				 <li id="ca-edit"><a href="/w/index.php?title=Multiple_myeloma&amp;action=edit" title="You can edit this page. &#10;Please use the preview button before saving. [e]" accesskey="e">Edit this page</a></li>
				 <li id="ca-history"><a href="/w/index.php?title=Multiple_myeloma&amp;action=history" title="Past versions of this page [h]" accesskey="h">History</a></li>			</ul>
		</div>
	</div>
	<div class="portlet" id="p-personal">
		<h5>Personal tools</h5>
		<div class="pBody">
			<ul>
				<li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Multiple_myeloma" title="You are encouraged to log in; however, it is not mandatory. [o]" accesskey="o">Log in / create account</a></li>
			</ul>
		</div>
	</div>
	<div class="portlet" id="p-logo">
		<a style="background-image: url(http://upload.wikimedia.org/wikipedia/en/b/bc/Wiki.png);" href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z"></a>
	</div>
	<script type="text/javascript"> if (window.isMSIE55) fixalpha(); </script>
	<div class='generated-sidebar portlet' id='p-navigation'>
		<h5>Navigation</h5>
		<div class='pBody'>
			<ul>
				<li id="n-mainpage-description"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z">Main page</a></li>
				<li id="n-contents"><a href="/wiki/Portal:Contents" title="Guides to browsing Wikipedia">Contents</a></li>
				<li id="n-featuredcontent"><a href="/wiki/Portal:Featured_content" title="Featured content — the best of Wikipedia">Featured content</a></li>
				<li id="n-currentevents"><a href="/wiki/Portal:Current_events" title="Find background information on current events">Current events</a></li>
				<li id="n-randompage"><a href="/wiki/Special:Random" title="Load a random article [x]" accesskey="x">Random article</a></li>
			</ul>
		</div>
	</div>
	<div id="p-search" class="portlet">
		<h5><label for="searchInput">Search</label></h5>
		<div id="searchBody" class="pBody">
			<form action="/w/index.php" id="searchform"><div>
				<input type='hidden' name="title" value="Special:Search"/>
				<input id="searchInput" name="search" type="text" title="Search Wikipedia [f]" accesskey="f" value="" />
				<input type='submit' name="go" class="searchButton" id="searchGoButton"	value="Go" title="Go to a page with this exact name if one exists" />&nbsp;
				<input type='submit' name="fulltext" class="searchButton" id="mw-searchButton" value="Search" title="Search Wikipedia for this text" />
			</div></form>
		</div>
	</div>
	<div class='generated-sidebar portlet' id='p-interaction'>
		<h5>Interaction</h5>
		<div class='pBody'>
			<ul>
				<li id="n-aboutsite"><a href="/wiki/Wikipedia:About" title="Find out about Wikipedia">About Wikipedia</a></li>
				<li id="n-portal"><a href="/wiki/Wikipedia:Community_portal" title="About the project, what you can do, where to find things">Community portal</a></li>
				<li id="n-recentchanges"><a href="/wiki/Special:RecentChanges" title="The list of recent changes in the wiki [r]" accesskey="r">Recent changes</a></li>
				<li id="n-contact"><a href="/wiki/Wikipedia:Contact_us" title="How to contact Wikipedia">Contact Wikipedia</a></li>
				<li id="n-sitesupport"><a href="http://wikimediafoundation.org/wiki/Donate" title="Support us">Donate to Wikipedia</a></li>
				<li id="n-help"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia">Help</a></li>
			</ul>
		</div>
	</div>
	<div class="portlet" id="p-tb">
		<h5>Toolbox</h5>
		<div class="pBody">
			<ul>
				<li id="t-whatlinkshere"><a href="/wiki/Special:WhatLinksHere/Multiple_myeloma" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j">What links here</a></li>
				<li id="t-recentchangeslinked"><a href="/wiki/Special:RecentChangesLinked/Multiple_myeloma" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</a></li>
<li id="t-upload"><a href="/wiki/Wikipedia:Upload" title="Upload files [u]" accesskey="u">Upload file</a></li>
<li id="t-specialpages"><a href="/wiki/Special:SpecialPages" title="List of all special pages [q]" accesskey="q">Special pages</a></li>
				<li id="t-print"><a href="/w/index.php?title=Multiple_myeloma&amp;printable=yes" rel="alternate" title="Printable version of this page [p]" accesskey="p">Printable version</a></li>				<li id="t-permalink"><a href="/w/index.php?title=Multiple_myeloma&amp;oldid=281211687" title="Permanent link to this version of the page">Permanent link</a></li><li id="t-cite"><a href="/w/index.php?title=Special:Cite&amp;page=Multiple_myeloma&amp;id=281211687">Cite this page</a></li>			</ul>
		</div>
	</div>
	<div id="p-lang" class="portlet">
		<h5>Languages</h5>
		<div class="pBody">
			<ul>
				<li class="interwiki-ar"><a href="http://ar.wikipedia.org/wiki/%D9%88%D8%B1%D9%85_%D9%86%D9%82%D9%88%D9%8A_%D9%85%D8%AA%D8%B9%D8%AF%D8%AF">العربية</a></li>
				<li class="interwiki-bn"><a href="http://bn.wikipedia.org/wiki/%E0%A6%AC%E0%A6%B9%E0%A7%81%E0%A6%B8%E0%A6%82%E0%A6%96%E0%A7%8D%E0%A6%AF%E0%A6%95_%E0%A6%AE%E0%A6%9C%E0%A7%8D%E0%A6%9C%E0%A6%BE%E0%A6%95%E0%A7%8B%E0%A6%B7%E0%A6%BE%E0%A6%B0%E0%A7%8D%E0%A6%AC%E0%A7%81%E0%A6%A6">বাংলা</a></li>
				<li class="interwiki-da"><a href="http://da.wikipedia.org/wiki/Myelomatose">Dansk</a></li>
				<li class="interwiki-de"><a href="http://de.wikipedia.org/wiki/Multiples_Myelom">Deutsch</a></li>
				<li class="interwiki-es"><a href="http://es.wikipedia.org/wiki/Mieloma_m%C3%BAltiple">Español</a></li>
				<li class="interwiki-fr"><a href="http://fr.wikipedia.org/wiki/My%C3%A9lome_multiple">Français</a></li>
				<li class="interwiki-it"><a href="http://it.wikipedia.org/wiki/Mieloma_multiplo">Italiano</a></li>
				<li class="interwiki-he"><a href="http://he.wikipedia.org/wiki/%D7%9E%D7%99%D7%90%D7%9C%D7%95%D7%9E%D7%94_%D7%A0%D7%A4%D7%95%D7%A6%D7%94">עברית</a></li>
				<li class="interwiki-nl"><a href="http://nl.wikipedia.org/wiki/Multipel_myeloom">Nederlands</a></li>
				<li class="interwiki-ja"><a href="http://ja.wikipedia.org/wiki/%E5%A4%9A%E7%99%BA%E6%80%A7%E9%AA%A8%E9%AB%84%E8%85%AB">日本語</a></li>
				<li class="interwiki-pl"><a href="http://pl.wikipedia.org/wiki/Szpiczak_mnogi">Polski</a></li>
				<li class="interwiki-pt"><a href="http://pt.wikipedia.org/wiki/Mieloma_m%C3%BAltiplo">Português</a></li>
				<li class="interwiki-ru"><a href="http://ru.wikipedia.org/wiki/%D0%9C%D0%B8%D0%B5%D0%BB%D0%BE%D0%BC%D0%BD%D0%B0%D1%8F_%D0%B1%D0%BE%D0%BB%D0%B5%D0%B7%D0%BD%D1%8C">Русский</a></li>
				<li class="interwiki-fi"><a href="http://fi.wikipedia.org/wiki/Myelooma">Suomi</a></li>
				<li class="interwiki-sv"><a href="http://sv.wikipedia.org/wiki/Myelom">Svenska</a></li>
			</ul>
		</div>
	</div>
		</div><!-- end of the left (by default at least) column -->
			<div class="visualClear"></div>
			<div id="footer">
				<div id="f-poweredbyico"><a href="http://www.mediawiki.org/"><img src="/skins-1.5/common/images/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" /></a></div>
				<div id="f-copyrightico"><a href="http://wikimediafoundation.org/"><img src="/images/wikimedia-button.png" border="0" alt="Wikimedia Foundation"/></a></div>
			<ul id="f-list">
					<li id="lastmod"> This page was last modified on 2 April 2009, at 02:36.</li>
					<li id="copyright">All text is available under the terms of the <a class='internal' href="http://en.wikipedia.org/wiki/Wikipedia:Text_of_the_GNU_Free_Documentation_License" title="Wikipedia:Text of the GNU Free Documentation License">GNU Free Documentation License</a>. (See <b><a class='internal' href="http://en.wikipedia.org/wiki/Wikipedia:Copyrights" title="Wikipedia:Copyrights">Copyrights</a></b> for details.) <br /> Wikipedia&reg; is a registered trademark of the <a href="http://www.wikimediafoundation.org">Wikimedia Foundation, Inc.</a>, a U.S. registered <a class='internal' href="http://en.wikipedia.org/wiki/501%28c%29#501.28c.29.283.29" title="501(c)(3)">501(c)(3)</a> <a href="http://wikimediafoundation.org/wiki/Deductibility_of_donations">tax-deductible</a> <a class='internal' href="http://en.wikipedia.org/wiki/Non-profit_organization" title="Non-profit organization">nonprofit</a> <a href="http://en.wikipedia.org/wiki/Charitable_organization" title="Charitable organization">charity</a>.<br /></li>
					<li id="privacy"><a href="http://wikimediafoundation.org/wiki/Privacy_policy" title="wikimedia:Privacy policy">Privacy policy</a></li>
					<li id="about"><a href="/wiki/Wikipedia:About" title="Wikipedia:About">About Wikipedia</a></li>
					<li id="disclaimer"><a href="/wiki/Wikipedia:General_disclaimer" title="Wikipedia:General disclaimer">Disclaimers</a></li>
			</ul>
		</div>
</div>

		<script type="text/javascript">if (window.runOnloadHook) runOnloadHook();</script>
<!-- Served by srv158 in 0.068 secs. --></body></html>
